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1. Introduction 
1.1 Tuberculosis 
Tuberculosis (TB) is an infectious disease that caused more deaths in the last 
200 years than any other infectious disease [1]. Throughout history TB has 
been known as a disease of poverty and is until today affecting the most 
vulnerable populations in the world [2, 3].  
In 1993 the World Health Organization (WHO) declared TB as a public health 
emergency and since then global efforts have been made to control the 
disease. With the human immunodeficiency virus (HIV) pandemic fuelling the 
spread of TB disease and furthermore the emergence of drug-resistances, even 
greater challenges in the fight against TB have come up. Although the United 
Nation’s Millennium Development Goal of “halting and reversing” TB incidence 
by 2015 was achieved on a global level, the global decline of the incidence rate 
is still slow and TB remains one of the deadliest infectious diseases in the world 
[4].  
1.1.1 Introduction to the disease 
Tuberculosis is an infectious disease that in most cases affects the lungs and is 
then called pulmonary TB. It is caused by genetically similar mycobacteria, 
which are together referred to as M. tuberculosis (MTB) complex. The MTB 
complex includes M. tuberculosis, which is the most frequent cause of TB in 
humans, M. bovis, M. africanum, M. microti and M. canetti [5]. 
TB is predominantly transmitted through infectious droplet nuclei in the air, 
which are produced by infected individuals while coughing, sneezing or talking. 
These aerosolized expectorations contain MTB and can remain in the air for 
several hours and once inhaled by another person, they can cause TB infection. 
The infectiousness of a person with TB depends amongst other factors on the 
bacillary load found in the sputum. Furthermore, the probability of transmission 
depends on the duration of exposure, the immune status of the person exposed 
and the environment where the exposure took place.  
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Most immunocompetent individuals are able to clear the infection or remain in 
an inactive stage, which is asymptomatic and not contagious. This is referred to 
as latent tuberculosis infection (LTBI). It is estimated that one third of the world 
population are infected with TB in this latent stage [6]. The lifetime risk of the 
infection progressing to active TB is estimated to be 5-15% for an 
immunocompetent person. In individuals that are immunocompromised due to 
HIV-coinfection, malnutrition or other immunosuppressive causes, the risk of 
developing an active symptomatic TB infection is much higher. For example, in 
HIV-infected persons, the risk of developing progressive disease is 20-30 times 
higher than in healthy individuals. It is estimated that a person with active TB 
disease can infect 10-15 other people within one year [7]. 
Typical symptoms of active pulmonary TB are persistent cough, weight loss, 
fever, night sweats and hemoptysis [8]. In case of extrapulmonary TB (EPTB), 
the clinical manifestation depends on the respective location and can involve a 
wide range of symptoms. 
The standard treatment regimen of drug-susceptible pulmonary TB is a six 
months course, comprising a two months initial phase with rifampicin, 
isoniazide, pyrazinamide and ethambutol (RHZE) and a four months 
continuation phase with rifampicin and isoniazid (RH) [9]. 
In case of rifampicin-resistant TB or multidrug-resistant TB, treatment with 
second line drugs is necessary.  
1.1.2 Diagnostic tests 
The main diagnostic tests for active TB include Chest X-rays, sputum smear 
microscopy and culture. In addition, since 2010 the WHO endorses a new 
molecular diagnostic test called Xpert® MTB/RIF assay.  
Chest x-rays are often used as a first indicator if active TB in presumed cases, 
since the majority of patients with pulmonary TB shows typical radiographic 
abnormalities. 
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Sputum smear microscopy is the oldest and most frequently used method to 
diagnose pulmonary TB, particularly in low- and middle-income countries. The 
acid-fast mycobacteria need special staining. The Ziehl-Neelsen stain is the 
most conventional staining for the detection of mycobacteria and slides can be 
read with an ordinary microscope. Although this method is very specific, it has 
with 54 – 64% a comparatively low sensitivity [10]. A more sensitive and equally 
specific method is the fluorochrome staining with auramine. However, this 
method requires special fluorescence microscopes. 
Culture remains the gold standard for diagnosing TB. However, it takes several 
weeks for a definite result. Culture also allows Drug sensitivity testing (DST) 
and is therefore indispensable for the diagnosis of drug-resistant TB.  
The Xpert® MTB/RIF assay allows the detection of MTB complex and rifampicin 
resistance by nucleic acid amplification within two hours. The sensitivity for 
sputum smear-positive cases is 98%. If used as an additional test after a 
negative microscopy result, Xpert® MTB/RIF has a sensitivity of 67% and 
increases TB detection among culture-positive cases by 23% [11]. Thus, Xpert® 
MTB/RIF is an excellent add-on test, but cannot replace sputum smear 
microscopy, culture or clinical evaluation of the patient. It is particularly 
recommended for testing people living with HIV and children, who have often 
sputum smear-negative results. In combination with the simultaneous testing for 
rifampicin resistance, which can serve as a proxy for MDR-TB, Xpert® MTB/RIF 
can contribute to the rapid detection of TB and thus early effective treatment 
initiation, which consequently reduces the risk of TB transmission (see section 
1.5.3). 
1.1.3 Global epidemiology 
In 2016, there were 10.4 million incident TB cases worldwide, out of which 10% 
were among people living with HIV. In the same year, there were 490 000 new 
cases of TB that is resistant to the two major anti-tuberculosis drugs rifampicin 
and isoniazide, so-called multidrug-resistant TB (MDR-TB). In addition, 110 000 
people were diagnosed with rifampicin-resistant TB (RR-TB). Out of the total of 
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600 000 of drug-resistant TB cases, which are eligible for second line treatment, 
only 22% were enrolled [12].   
The number of new TB cases reported to the WHO increased between 2013 
and 2016, which can be attributed to higher notification rates, most notably in 
India. However, there is still a 4.1 million gap between the estimated incidence 
and notified cases.  
Despite decreasing absolute numbers of TB deaths since the year 2000, TB 
remains the world’s deadliest disease from a single infectious agent and is a 
leading cause of death in people infected with HIV. In 2016, it killed an 
estimated 1.3 million people and another 374 000 people living with HIV [12].  
1.2 Strategies to fight TB 
1.2.1 Patient-focused strategies 
After TB had been declared as a public health emergency, the WHO introduced 
1994 the so-called DOTS strategy, which is a framework for effective TB control 
and stands for “Directly Observed Therapy, Short course”. One of its key 
operations is to establish directly supervised treatment services and patient 
education in primary health care facilities. Other operations include the 
establishment of national TB programs, standardized recording and reporting 
systems and regular supply of drugs and diagnostic material [13].  
1.2.2 Global strategies 
In 2015, a new era of global efforts to fight the TB epidemic has begun. In 
September 2015, 17 Sustainable Development Goals (SDGs) were adopted by 
the United Nations (UN) for the period of 2016 to 2030. In the SDG3 target 3.3 
the goal to “end the epidemics of AIDS, tuberculosis, malaria and neglected 
tropical diseases” by 2030 was set [14].  
In 2000, the Stop TB partnership, an international organization linked to the 
World Health Organization  (WHO), was founded and the Stop TB Strategy 
developed, which was succeeded by the End TB strategy in 2015. In the wake 
of the SDG and as a new post-2015 Global TB Strategy; the End TB strategy, 
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spanning the 2016 to 2035 period was elaborated and approved unanimously 
by the World Health Assembly in 2014. This strategy is closely linked to the 
SDGs and shares the overall target to end the global TB epidemic. The final 
targets are to reduce the absolute number of TB deaths and the incidence by 
95% and 90% respectively by 2035 and to ensure that no household faces 
catastrophic costs due to TB from the first milestone in 2020 onwards [15].   
The End TB strategy is hinging on three main pillars:  
 Pillar 1: Integrated, patient-centered TB care and prevention 
 Pillar 2: Bold policies and supportive systems 
 Pillar 3: Intensified research and innovation 
One of the key components of pillar 2 is to strengthen health policies and 
systems to prevent and end TB and to support the implementation of regulatory 
frameworks for, amongst others, infection control.  
1.3 Gabon’s healthcare system 
1.3.1 Introduction to the country  
Gabon is located at the equator in central Africa and has a population of 2 
million inhabitants, of which about 87% live in urban areas. Approximately 
88.5% of the country is covered by rain forest, which makes transport and 
access outside the main road axes difficult [16].   
Gabon’s economy is mainly based on the export of oil and tropical woods. 
Because of its high gross national income (GNI) per capita, the World Bank 
classifies Gabon as an upper middle-income country [17]. However, one third of 
the population is living below poverty level and the national income is extremely 
unequally distributed [18].  
Life expectancy is 65.8 years for women and 63.1 years for men [16]. Despite 
the increasing burden of non-communicable diseases like cancers, 
cardiovascular and chronic respiratory diseases, infectious diseases like 
HIV/AIDS, Malaria and TB are still amongst the leading causes of death [19]. 
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1.3.2 Administrative structure of the healthcare system 
The healthcare system in Gabon comprises ten sanitary regions (Libreville-
Owendo, Ouest, Sud-Est, Centre, Centre-Sud, Sud, Est, Centre-Est, Maritime 
and Nord) and 52 sanitary districts. 
The healthcare system is organized in three sectors: the public sector, 
encompassing civil and military healthcare structures, the para-public sector, 
represented by the Caisse Nationale de Sécurité Sociale (CNSS) and the 
private sector, comprising the profit oriented, non-profit and traditional 
healthcare sectors.  
The non-profit private sector is represented principally by the Albert Schweitzer 
Hospital in Lambaréné in the Moyen-Ogooué province (Centre) and the 
evangelist missionary Hospital of Bongolo in Lebamba, in the province of 
Ngounie (Centre Sud). 
As shown in Figure 1, the public civil sector is organized as a pyramidal system 
comprising the central, regional and periphery care levels. National policies and 
strategies are developed at the central level, coordinated by the Ministry of 
Health and, as far as TB control is concerned, by the director of the national TB 
control program (PNLT).  
The sanitary region is the intermediate level, responsible for technical support 
coordination and supervision of the sanitary districts. Its authority comprises the 
regional health directorate (DRS), the regional hospital and the Base 
d’épidémiologie (BELE), which is in charge of collecting epidemiological data 
and implementing the national TB strategies. 
The sanitary districts represent the most peripheric operational care unit in the 
healthcare pyramid and are therefore closest to the population. Their operating 
facilities comprise various healthcare centers and dispensaries.  
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Graph 1 ‘Healthcare pyramid’ of Gabon  
PNLT: Programme Nationale de Lutte contre la Tuberculose, DRS: Directeur Régional de la 
Santé, BELE: Base d’épidémiologie 
 
The sanitary region Centre corresponds to the Moyen-Ogooué province and is 
sub-divided into the sanitary departments Ogooué et Lacs and Abanga Bigne. 
According to the latest unpublished data from 2016 (provided by the DRS), the 
sanitary region Centre comprises 55 healthcare facilities, including two 
hospitals, one HIV clinic, two medical centers, three health centers, thirteen 
infirmaries, 31 dispensaries and three other healthcare facilities. 
1.3.3 Deficits and challenges 
Healthcare in Gabon is highly centralized. In rural communities, dispensaries 
provide the only direct access to primary healthcare, and resources are very 
limited. Due to the insufficient budget allocated to these facilities, basic material 
is often missing and maintenance is not performed. In most dispensaries, there 
is only one assistant nurse in charge for consultations and there are no 
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diagnostic means available. A small range of medication such as analgesics, 
anti-malarial drugs and certain antibiotics can be provided by the dispensary. 
However, patients who need special diagnostics and care have to be referred to 
the next hospital, which is often far to reach. Since transport is expensive and 
not affordable for a large part of the rural population, access to healthcare is 
often delayed or even impossible. 
The lack of comprehensively trained healthcare staff is another challenge in 
Gabon. Especially outside the capital, there is an urgent need for physicians 
and trained nurses. As mentioned above, consultations in dispensaries are 
often performed by assistant nurses, who are not adequately trained. The 
correct recognition of severe medical conditions such as TB at a periphery level 
and thus the need of referral to a higher-level hospital is therefore highly 
questionable.  
Furthermore, hospitals and laboratories are often insufficiently equipped. Many 
diagnoses are only clinically based, as often no adequate laboratory procedures 
or other diagnostic tests are available. In addition, drug-stock outs are common, 
posing unique challenges for long term treatment, such as for HIV or TB. 
1.4 TB control in Gabon 
1.4.1 Epidemiology 
Alongside HIV and malaria, TB is one of the leading causes of death in Gabon 
and a major threat to public health. With an estimated incidence of 485 per 
100,000 population in 2016 [12], Gabon is among the ten countries with the 
highest TB incidence in the world.  
Only little systematic data on TB epidemiology in Gabon is available and 
reporting systems are not consistent. Consequently, most data available can 
only be regarded as estimates and do not necessarily depict the real situation. 
In 2016 there were a total of 6,036 TB cases notified, of which 92% were 
pulmonary TB. Out of the latter 47% were bacteriologically confirmed and an 
estimated 230 were MDR/RR-TB cases, for which the resistance was laboratory 
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confirmed in 30 cases only. The total treatment coverage was estimated to be 
58% [20]. 
According to the WHO, 54% of the TB patients in 2016 had been tested for HIV 
and 21% were found to be co-infected with HIV. However, for 46% of the TB 
patients the HIV status was unknown [20]. A retrospective study conducted in 
Lambaréné, evaluating 729 hospitalized TB patients between 2008 and 2011 
found a co-infection rate of 34 % [21] and the so-called Panepi study, which 
was conducted by Bélard et al. in Lambaréné between 2012 and 2014 revealed 
an even higher rate of 42% [22]. This emphasizes the enormous impact of HIV 
co-infection on TB control. 
1.4.2 National tuberculosis program 
Gabon’s national TB control program “programme national de lutte contre la 
tuberculose” (PNLT) was founded in 1997 and has as its general objective to 
reduce the TB mortality, morbidity and transmission until TB stops posing a 
threat to Gabon’s public health, in line with the global Stop TB strategy [23]. 
The PNLTs specific objectives are:  
 To detect at least 70% of TB cases 
 To cure at least 85% of detected TB cases 
 To reduce the lost-to-follow-up rate to under 5% 
 To reduce the mortality rate to under 5% 
 To ensure clinical and psycho-social support in cases of co-infection 
TB/HIV 
 To ensure the support of MDR-TB 
 To ensure TB infection control  
Although the PNLT officially adapted the Stop TB strategy, it failed to implement 
DOTS in the country. However, the PNLT aims to contribute to the 
strengthening of the healthcare system in terms of human resources, finances 
and improved reporting systems, to ensure comprehensive data collection. The 
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provision of adequate training for healthcare personnel and the promotion of 
research are indicated as further key activities of the PNLT. 
The PNLT’s strategy targets all levels of the healthcare system. While 
healthcare centers on the central and regional level are responsible for 
diagnosis, management of TB drug supplies and case notifications, the 
periphery facilities represent the operational care level. Hence, they play a 
crucial role in TB control and need to be equipped accordingly. According to the 
PNLT, their tasks include the identification of patients with symptoms 
suggestive of TB, their referral to a diagnosis and treatment center (CDT), 
contact screening of index cases, treatment surveillance and social mobilization 
in the communities.  
1.4.3 Major challenges in TB control  
1.4.3.1 Limited access to diagnostics and care 
A great part of the population has no access to primary healthcare services due 
to a lack of financial means. As in most provinces of the country there are no 
CDTs for TB, the access to diagnostic and treatment initiation is very limited. 
The often long distance accompanied by high transport costs to the closest 
treatment center has a strongly negative impact on the treatment adherence. A 
far distance to the treatment center has been associated with treatment 
interruption and identified as a risk factor for unfavorable treatment outcome in 
the Panepi cohort [22]. To enable the implementation of DOTS, adequate 
community based TB care would have to become available. 
Although case notification rates for all forms of TB are increasing, a 
considerable part is still based exclusively on clinical diagnosis. There is an 
urgent need for a comprehensive laboratory network covering all provinces of 
Gabon.   
1.4.3.2 Insufficient case management and treatment outcomes 
With a treatment success rate of only 50% in 2015 [20], rates are still far from 
the PNLTs minimum target of 85%. Limited access to TB care and frequent 
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drug stock-outs [24] contribute to this situation. With 32% in 2016 (unpublished 
PNLT data) the rate of TB patients lost to follow up is high and still far from the 
target of 5% the PNLT is aiming for. The Panepi study [22] showed, despite 
active follow up, a lost-to-follow-up rate of 16.9% and while 53% of the enrolled 
patients successfully completed their treatment, only 8% could be considered 
as cured by smear- and/or culture-negative sputum. Furthermore, the Panepi 
study showed that case management was often not optimal, e.g. in terms of 
deviations from the treatment regimen foreseen in the national guidelines. This 
indicates that the national guidelines are not yet fully implemented throughout 
the country. 
1.4.3.3 Emergence of drug resistance 
Although the rate of MDR-TB is estimated to be 2.8% and 13.0% among new 
and retreated TB cases respectively [20], there was no consistent capacity for 
MDR-TB testing in the country until 2015. Diagnosis was based exclusively on 
clinical suspicion and patient history [24]. However, as capacity to perform DST 
and rapid testing for RR using the Xpert® MTB/RIF was built up, emergence of 
drug resistance became evident [22, 25]. In addition, there was no second line 
treatment available in the country until 2015, contributing to active transmission 
in the community. Furthermore in 2016, the first extensively drug-resistant 
tuberculosis (XDR-TB) case was notified in the country (unpublished laboratory 
data). 
A national drug resistance survey is needed to understand the true burden of 
MDR-TB and XDR-TB in Gabon. In addition, DST and second line treatment 
must become available throughout the country, as the surge of drug-resistant 
TB (DR-TB) threatens to deteriorate TB control in Gabon. 
1.4.3.4 Childhood TB 
Data on childhood TB is scarce and a recent retrospective study conducted by 
Flamen et al. suggests that the prevalence might be a lot higher than the 
numbers reported [26].  
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The PNLT reports a proportion of 1 to 2 % of TB cases in patients below 15 
years and most are based on clinical diagnosis [27]. The Panepi study showed 
a rate of 15 % cases in patients aged less than 18 years in their cohort, out of 
which 36 % were bacteriologically confirmed through microscopy and 6 % had 
EPTB [22].  
Due to the difficult diagnosis and inconsistent notification systems, the true 
burden of childhood TB in Gabon remains unclear. 
1.4.3.5 Lack of financial support 
Although Gabon ranks among the countries with the highest incidence rate 
globally, it has, due to its small population, a low incidence in absolute numbers. 
In combination with the country’s classification as a middle-income country, this 
puts Gabon in a suboptimal position and leads to disadvantages concerning 
financial support and funding in TB control. However, to be able to control TB 
globally, more attention needs to be paid to such countries. 
1.5 TB infection control in healthcare settings 
1.5.1 Background 
Healthcare workers (HCW) all over the world have been shown to be at higher 
risk to be infected and develop active TB than the general population [28-30]. A 
recent meta-analysis regarding the prevalence of LTBI in seven high burden 
countries showed a pooled prevalence of 47% amongst HCW [31]. A high rate 
of LTBI among HCW was also observed in a cross-sectional study conducted in 
Rwanda, in which, with a prevalence of 62%, HCW were found to have a 
significantly higher rate of LTBI than the control group of school workers (39%) 
from the same region [32]. Cases of active TB are similarly increased among 
HCW. For example, a retro- and prospective cohort study conducted in 
southern India revealed a 3.1 higher incidence of active TB than the general 
population amongst postgraduate residents working in a tertiary care teaching 
hospital [33]. Particularly in high prevalence countries, TB infection control 
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(TBIC) measures are therefore crucial, as HCW are at high risk to be exposed 
to infectious TB patients. 
TBIC is a set of measures that aims to prevent TB transmission within a certain 
population. This complements general infection control efforts and focuses on 
the reduction of the transmission of airborne infections. The importance of TBIC 
in healthcare facilities was for a long time underestimated, and consequently 
neglected in the policies of TB control. However, the emergence of drug-
resistances and accumulating evidence of MDR-TB and XDR-TB transmission 
in hospitals [34-36] has raised increasing awareness towards this topic, and 
efforts have been made to elaborate and implement TBIC strategies in many 
countries.  
Particularly in settings where there is a high prevalence of HIV-infection, the 
avoidance of TB transmission in healthcare settings is of paramount 
importance. In often crowded areas of healthcare facilities such as waiting 
areas or emergency rooms, HCW as well as other patients are likely to be 
exposed to infectious TB patients, who are often not yet recognized as such. 
Therefore managerial, administrative and environmental infection control 
measures should be well implemented, and adequate personal protective 
equipment should be made available and used, in order to protect HCW from 
occupational exposure and other people in the healthcare environment from 
nosocomial spread.  
TBIC in healthcare settings implies fast recognition, diagnosis and treatment 
initiation of TB cases and can thus be considered as a core activity of TB 
control in general. In addition, infection control states one of the pillars of the 
End TB strategy [4]. 
1.5.2 WHO policy on TBIC in healthcare settings 
The following description of TBIC activities in healthcare settings refers to the 
respective WHO policy on TBIC in healthcare settings [37], if not otherwise 
noted. 
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1.5.2.1 Managerial activities 
A managerial framework is the foundation for any TBIC activity and has 
therefore to be provided at a national, sub-national and facility level, in order to 
enable health facilities to implement TBIC measures effectively. This includes 
creating a specific TBIC coordinating body, which will amongst others provide 
guidance regarding appropriate facility designs and ensure the surveillance of 
TB incidence among HCW. It is recommended to assess and monitor TBIC 
measures continuously at all levels of the healthcare system.  
Another component of the managerial activities is the development of a budget 
and human resource plan required for the implementation of infection control 
strategies. Therefore, gaps regarding human resources need to be identified 
and professional competence of HCW at all levels of the health system 
ensured.  
The general recommendations need to be adapted to the requirements and 
socioeconomic background of individual countries. In addition, the activities 
should build on already existing national infection prevention and control 
policies and coordinate closely with TB, HIV and occupational health programs.  
1.5.2.2 Administrative controls 
Administrative controls demonstrably reduce the risk of TB transmission in 
healthcare facilities and their implementation should therefore be of first priority. 
In general, administrative infection control measures aim to minimize the 
generation of infectious aerosols in the facility and provide prevention and care 
packages for HIV-positive HCW. Administrative TBIC measures include the 
following key components: 
 Triage and separation 
In order to reduce the time TB infected patients spend in the facility and 
thus the risk of spreading infectious droplets in the air, presumed TB 
cases must be promptly identified, diagnosed and started on anti-
tuberculous treatment as fast as possible. Therefore triage, i.e. 
prioritizing patients with symptoms indicative of TB is crucial. In any 
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case, presumed TB cases and confirmed TB patients have to be 
separated from other patients; particularly from those who are especially 
susceptible to TB such as young children or immunocompromised 
persons. Presumed TB cases in outpatient departments should be 
placed in well ventilated possibly separate waiting areas and their 
diagnosis should be treated as a matter of priority. For hospitalized TB 
patients, especially in cases with confirmed drug-resistances, isolation 
rooms should be available. 
 Cough etiquette and respiratory hygiene 
Another way to minimize the production of infectious droplet nuclei from 
TB patients is the practice of cough etiquette and respiratory hygiene. 
This includes covering mouth and nose when sneezing or coughing and 
generally contributes to the control of respiratory infections. Pieces of 
cloth, tissues or surgical masks can be used as physical barriers for this 
purpose. If not available, patients, visitors as well as HCW themselves 
should be instructed to cover their mouth and nose with their arm or 
hands, which then must be washed immediately. Although there is little 
evidence about the benefit of placing surgical masks on coughing 
patients, the WHO highly recommends this practice based on current 
understanding of TB transmission and a strong theoretical basis. Hence, 
these practices should be promoted amongst all persons attending the 
health facility, including staff. Educational materials such as posters 
depicting cough hygiene should be prominently placed e.g. in waiting 
areas and consultation rooms. 
 Minimizing time spent in healthcare facilities 
It is generally recommended to manage TB patients as outpatients, in 
order to minimize the risk of nosocomial spread. If hospitalization is 
required due to certain medical conditions or complications, patients 
should be separated from susceptible patients.  
To ensure that infectious patients spend as little time as possible in the 
facility, diagnostic delays should be minimized. Furthermore, HCW 
should avoid placing such patients in poorly ventilated and crowded 
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areas. The priority should be a community-based approach for the 
management of TB patients, in terms of educating household members 
and other close contacts on TBIC. 
 Prevention and care for HCW 
All HCW should be provided with educational material and encouraged to 
undergo TB diagnostic evaluation if they have symptoms indicative of 
TB. Equally important is that they are offered confidential HIV testing and 
counseling. This is particularly recommended in settings with high 
prevalence of HIV. If HCW are diagnosed with HIV, they should be 
provided with antiretroviral therapy as well as regular screening for active 
TB. If HIV-positive HCW are working in areas with a high risk of exposure 
to infectious TB patients, they should be relocated to a position with 
lower risk of infection. In addition, HIV-positive HCW should be put on 
isoniazide preventive therapy, as this has been shown to significantly 
reduce the incidence of active TB in people living with HIV [38]. 
1.5.2.3 Environmental controls 
Environmental controls in terms of natural, mixed-mode and mechanical 
ventilation play an essential role in controlling airborne infections and are 
strongly recommended for preventing spread of TB in healthcare facilities. In 
general, they serve to reduce the concentration and spread of infectious 
particles in the air. The type of ventilation system used strongly depends on the 
facility structure, climatic and socioeconomic conditions. 
In limited-resource settings, expensive environmental measures such as 
ultraviolet germicidal irradiation (UVGI) and negative pressure rooms are often 
difficult to implement and maintain. However, opening windows and doors in 
order to increase the natural ventilation can be a simple alternative. This has 
even been shown to be more effective than costly mechanical ventilation, 
particularly in rooms with high ceilings and large windows [39]. Natural 
ventilation can be optimized by ensuring open windows on opposite walls and 
should always be maximized before taking into account other ventilation 
systems. 
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1.5.2.4 Personal protective equipment  
Personal protective equipment (PPE) stands lowest in the TBIC measure 
hierarchy. However, the usage of particulate respirators such as N95 or FFP2 
respirators in high risk areas is strongly recommended by the WHO as well as 
the Centers for Disease control and Prevention (CDC) [40]. Although available 
evidence is low, adequate respirators can theoretically prevent HCW from 
inhaling infectious aerosols. They should be worn by HCW for example during 
sputum induction procedures or when caring for potentially infectious MDR-TB 
and XDR-TB patients. Accordingly, HCW should receive training in the correct 
use of these respirators and fit testing should be considered.  
1.5.3 FAST strategy 
The FAST strategy [41] is another administrative approach to infection control in 
healthcare settings and is particularly feasible in limited-resource settings. 
FAST stands for: Find cases Actively by cough surveillance and rapid molecular 
sputum testing, Separate safely, and Treat effectively. It focuses on the fast 
recognition of presumed TB cases, since untreated and not-yet-evaluated TB 
infected patients pose the biggest risk of transmission.  
The strategy is based on the idea that once a patient is identified as a 
presumed TB case, control measures can be put in place, and intervention in 
terms of treatment makes transmission unlikely. It is assumed that coughing 
patients with unsuspected TB or unsuspected drug-resistance are the most 
frequent cause of institutional spread of TB. In addition, several studies have 
shown that active case finding reveals a higher rate of TB amongst patients 
attending the facility [42, 43]. FAST therefore focuses on the enhanced case 
finding through cough surveillance, testing with rapid molecular sputum tests 
such as Xpert® MTB/RIF and following effective treatment. This reduces the 
time spent in the facility; and the fast recognition of rifampicin resistance allows 
the initiation of effective treatment immediately, whereas conventional DST 
would take months to identify DR-TB cases.  
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Although there is yet no evidence that this strategy reduces TB transmission, 
we can logically conclude that due to the reduced duration of exposure, 
institutionally acquired TB infections can be decreased proportionately. 
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2. Methods 
2.1 Study rationale 
There is a high prevalence of TB in Gabon, aggravated by accumulating 
evidence of a high MDR-TB prevalence [22] posing an even greater challenge 
for effective disease control. As aforementioned, literature indicates that TB 
infection rates among HCW are higher than in the average population. We can 
therefore assume that in Gabon, HCW are similarly at greater risk for TB 
infection. In line with this, TB cases, including MDR-TB, have been notified 
among HCW in the country during recent years, and there is a report of at least 
one fatal case. Additionally, HIV prevalence is estimated at 4.1% in the general 
population amongst adults aged 15-49, reaching 5.8% in the Moyen-Ogooué 
province [44]. This rate can presumably be still higher amongst those attending 
or admitted to a hospital. In such settings, it is particularly vital to avoid the 
spread of TB within healthcare environments. 
In the province of Moyen-Ogooué, as in the rest of the country, resources are 
limited and prevention of institutional transmission of TB is a challenge. 
However, as indicated above, there are good low-cost alternatives such as 
optimizing natural ventilation [39] and implementing the FAST strategy [41]. 
Although the PNLT includes infection control as one of its specific objectives 
[23], there are currently no national guidelines available for TBIC. 
Consequently, it is assumed that TBIC is not optimal. Furthermore, due to a 
lack of evidence of formal TB and TBIC training, it is suspected that health care 
workers are not adequately prepared to take appropriate precautions during the 
management of presumed TB cases. 
It is of paramount importance to ensure that TBIC guidelines are elaborated, 
institutional managerial frameworks designed and corresponding infection 
control measures implemented. Furthermore, knowledge about TB, mode of 
transmission and its clinical presentation is crucial among HCW, in order to 
enable them to identify presumed TB cases and manage them adequately 
early.  
24 
 
The TB infection control evaluation (TB-ICE) study therefore aims to conduct a 
baseline assessment of TBIC in health facilities at different levels of the 
healthcare system in the Moyen-Ogooué province and to provide insight into the 
knowledge, attitudes and TBIC practices of HCW. Findings will form the factual 
basis for the design, implementation, follow up and monitoring of future TBIC 
interventions in Gabon and help to advise about training curricula for healthcare 
personnel. 
2.2 Study design and objectives 
A cross-sectional observational study using two methods was performed: a 
comprehensive facility assessment and a knowledge, attitude and practice 
(KAP) survey amongst HCW with regard to TB.  
The primary objectives of the study were:  
 To conduct a structured assessment of regional healthcare facilities 
including managerial and administrative, environmental as well as 
personal protection infection control measures regarding pulmonary 
TB in comparison to the WHO recommendations 
 To identify current knowledge, attitudes and practices of HCW 
concerning TB and TBIC in regional urban, semi-urban and rural 
hospitals and dispensaries in the region of Moyen-Ogooué 
 To identify factors that could possibly hinder the implementation of 
effective TBIC guidelines  
The secondary objectives were: 
 To identify differences with regard to knowledge, attitude and practice 
between subpopulation groups, e.g. on different health care levels 
 To establish a baseline of TBIC at hospital and dispensaries level that 
will enable a supervision and monitoring framework for the 
subsequent implementation of infection control activities  
25 
 
2.3 Study setting 
2.3.1 Study period 
The study started in November 2016 and ended in March 2017. Hospitals were 
assessed during a period of 4 weeks. Each department selected for 
assessment was visited over a period of 2 to 3 days for observation and 
interviews. The dispensaries were evaluated within one day. 
2.3.2 Study sites 
2.3.2.1 Albert Schweitzer Hospital (HAS) 
HAS comprises an outpatient department, an emergency department, an 
internal medicine ward, a pediatric ward, a surgical ward as well as a maternity 
ward. It has a total capacity of 150 beds and is therefore the biggest hospital in 
Lambaréné. Sputum samples of TB patients and suspects are referred to TB 
laboratory of the Centre de Recherches Médicales de Lambaréné (CERMEL), 
as the hospital laboratory does not perform TB diagnostic procedures since 
2015. 
2.3.2.2 Centre Hospitalier Régional „Georges Rawiri” de Lambaréné 
(GHRGR) 
CHRGR has a total capacity of 98 beds and accounted for 12 788 outpatient 
consultations, as well as 3532 hospitalized patients in 2015. It is therefore the 
second biggest hospital in Lambaréné and the public reference hospital in the 
region of Moyen-Ogooué. 
In 2015 the first MDR-TB treatment unit in Gabon was set up at the CHRGR in 
close collaboration with the CERMEL. It was the first site in the country where 
patients were receiving second line treatment, following the shorter MDR-TB 
regimen of 9 -12 months, the so-called “Bangladesh protocol” [45].  
In addition, the hospital has an outpatient clinic, an emergency department, an 
internal medicine ward, a tropical diseases ward, including the MDR-TB 
treatment unit, a surgical ward, a maternity ward and a pediatric ward. Sputum 
26 
 
samples for mycobacterial analysis are routinely referred to the CERMEL’s TB 
laboratory. 
2.3.2.3 Centre de Traitement Ambulatoire (CTA) 
CTA is the public HIV clinic in Lambaréné, offering outpatient HIV testing, 
counseling and treatment. HIV/TB co-infected patients are offered ambulatory 
anti-tuberculous treatment. Sputum samples are analyzed on site with Ziehl-
Neelson staining microscopy and are sent to the TB laboratory of the CERMEL 
for confirmation. 
2.3.2.4 Dispensaries 
Dispensaries are at the lowest level of the healthcare pyramid and thus the 
most peripheral operational unit of the healthcare system in Gabon. As patients 
from rural areas often seek consultation at the local dispensary in the first place, 
HCW there play a crucial role in TB control. The ability of the respective HCW of 
recognizing TB suspects and referring the patient to another facility for 
diagnosis and treatment is of paramount importance.  
In the sanitary region Centre, i.e. the province of Moyen-Ogooué, there are in 
total 31 dispensaries, 25 and six in the departments Ogooué et Lacs and 
Abanga Bigne respectively. Out of the 25 dispensaries in the Ogooué et Lacs 
department, 20 were operational during the time of the study (data provided by 
the DRS). Four of them are located in the city of Lambaréné and are therefore 
considered as urban dispensaries.  
2.4 Sample size and study population 
The facilities for the assessment were chosen conveniently. However, it was 
aimed to select a representative range of facilities from the periphery and 
intermediate level of the healthcare system. The two hospitals, the CTA and all 
17 operational dispensaries on the main road axes Bifoun-Lambaréné and 
Lambaréné-Fougamou of the Ogooué et Lacs department were selected for 
assessment.  
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In the hospitals, the following departments were considered as risk areas for TB 
transmission and henceforth chosen for the assessment: The outpatient 
department (OPD), the emergency department (ED), the internal medicine ward 
(IM) and the pediatric ward (PD). Additionally the MDR-TB treatment unit (MT) 
of the tropical diseases ward at CHRGR was assessed. The radiology 
departments were looked at as part of the OPD assessment. 
For the KAP survey, HCW were approached during the time of assessment. 
Thus, all HCW who were present in the respective department or dispensary 
during the assessment period were asked to participate in the KAP survey. In 
addition, staff from the radiology department was included as well as any other 
staff wishing to participate in the survey. Due to a lack of reliable statistical 
parameters, it was not possible to conduct a sample size calculation in 
advance. However, all potential participants available during the study period 
were approached and therefore the maximum number of KAP surveys possible 
was conducted. 
Potential occupational exposure to TB infected patients and/or presumed TB 
cases was the only criterion for participation in the KAP survey. Consequently, 
anyone working in a healthcare facility with regular patient contact was eligible.  
2.5 Study procedures and variables  
2.5.1 Facility assessment 
A comprehensive facility assessment tool was developed as a combination of 
two assessment tools, namely the tool from the WHO guide on the 
implementation of the WHO policy of TBIC in healthcare settings [46] and from 
the manual “Implementing TB infection control in health care facilities” from the 
Reproductive Health and HIV Research Unit of the University of the 
Witwatersrand, South Africa [47]. Small adjustments were made to fit them to 
the situation in Gabon. For the assessment of dispensaries a shortened version 
was used. See Annex 1 for the complete assessment tool.  
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The hospitals, the CTA and the dispensaries were assessed regarding 
managerial, administrative and environmental infection control measures, 
patient education and measures of personal risk reduction for HCW. 
The facility assessment was conducted through observation, reviewing of 
available registers and patient files as well as in-depth interviews with the 
person in charge of infection control or the head of department, if no infection 
control manager was in place.  
Each selected department in the hospitals was visited two to three days. 
Dispensaries were assessed within one day. Environmental controls, patient 
management and the facility structure were evaluated through observation. Any 
other relevant observations made which were not specifically parts of the 
assessment tool were documented. If available, TB registers and patient files 
from TB patients who had visited the facility in the past three months were 
reviewed. In the dispensaries the general patient register was reviewed 
regarding the number of patients presenting with a cough during the past three 
months. Procedures and policies that could not be assessed by observation 
were inquired during the in-depth interviews. If applicable, documentation was 
requested in order to confirm answers given in the interview.     
2.5.2 KAP survey 
The KAP survey was conducted using an interviewer-administered semi-
structured questionnaire that was developed for this study. Questions were 
partly adapted from the Advocacy, Communication and Social mobilization 
(ASCM) for TB control guide to developing KAP surveys [48] and elaborated for 
this specific purpose after extensive literature review. 
The questionnaire was validated in a pilot study with ten HCW at the CERMEL, 
including five nurses, three doctors and two other clinical staff with patient 
contact such as project coordinators. Participants were asked if the questions 
were clear and small adjustments were made accordingly. See Annex 2 for the 
complete KAP questionnaire.   
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Participation in the study was voluntary. Prior to the interviews, HCW willing to 
participate were explained the purpose and benefits of the study and reminded 
that all personal data collected will be kept entirely confidential. After written 
informed consent was obtained, the interviewer started to read out the 
questionnaire to the participant and documented his or her respective answers. 
Interviews were held in a separate environment in order to ensure the 
confidentiality of the responses. In case of questions, non-leading explanations 
were given by the interviewer. 
The questionnaire was divided into four parts: demographics and information on 
personal TB history; general knowledge about TB; attitude towards TB and TB-
infected patients; and practical experience regarding infection control of 
pulmonary TB.  
2.5.2.1 Demographic and general information 
In order to maintain the anonymity of the questionnaires, no personal identifying 
information was obtained, so that information could not directly be tracked back 
to the interviewee. HCW were asked about their age, educational level, current 
job position and professional experience in healthcare. Furthermore their 
personal and family TB history was obtained.  
2.5.2.2 Knowledge 
The knowledge part comprised 16 knowledge questions, including ten single 
answer questions and six questions with multiple correct answers. The basic 
knowledge was assessed with one question about the cause of TB, one about 
symptoms, one about diagnostic, three about transmission and prevention, four 
about treatment, two about risk factors, three about MDR-TB and one about 
LTBI.  
Knowledge questions were elaborated that were considered to cover the 
minimum basic knowledge required for working with presumed TB cases and 
TB patients. Correctness of scored answers was ensured by reviewing most 
recent literature. 
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The questions were read out to the interviewee as open-ended questions in 
order to avoid guessing the correct biomedical answer. The answer was 
recorded by the interviewer in terms of pre-categorized answers on the 
questionnaire. Interviewees were told if there was more than one correct 
answer possible. Each correct answer was scored one, incorrect answers were 
scored zero. In questions with multiple correct answers, each correct answer 
given was scored one. The maximum score was 27.  
For the question about symptoms, a score was given for the following 
symptoms: 
 Cough 
 Bloody sputum 
 Fever 
 Weight loss 
 Night sweats 
Regarding risk factors and risk groups the following answers were considered 
as correct: 
 People living with HIV/AIDS 
 Young children 
 Close contacts of a confirmed TB case 
 HCW 
 Laboratory staff 
 People with medical conditions that weaken the immune system (other 
than HIV) 
 People under immunosuppressive therapy 
 Undernourished people 
 People drinking alcohol 
 People smoking 
 People using drugs 
 Prisoners 
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Knowledge levels were defined as “poor” (0-10/<40%), “rather poor” (11-16/ 40-
60%), “good” (17-21/>60-80%) and “excellent” (22-27/>80%). 
2.5.2.3 Attitude 
The attitude part consisted of nine yes/no/not sure questions and four additional 
open questions used to gain more background information about the reason for 
certain attitudes. Data was synthesized descriptively.  
2.5.2.4 Practice 
The practice section comprised 10 items stating different infection control 
practices adapted from the WHO recommendations for TBIC in limited-resource 
settings [37]. The participants were asked to report their own actual practices in 
their current work position, regardless of the reasons why something was 
practiced or not. The response could be given in terms of a four item Likert-
Scale (never/sometimes/most of the times/always), which was later converted 
into dichotomous values (practiced/not practiced) for further analyses. Practices 
that could not be reported because the respective situation has not yet occurred 
to the HCW were marked as not applicable.  
2.5.3 Minimization of bias 
The social desirability of participants, which is a type of response bias, 
describes the tendency of respondents to give answers which they consider to 
be socially expected of them. This was minimized by emphasizing during the 
informed consent process that all responses were strictly confidential and that 
no personal identifying information will be noted on the questionnaire. In 
addition, all questionnaires were administered by the same interviewer, 
ensuring that questions were asked in the same way.  
By piloting the questionnaire with HCW from CERMEL prior to the study, it was 
aimed to minimize potential information bias. Leading or unclear questions were 
eliminated or rephrased. During the study period, HCW were asked not to talk 
about the questionnaire with their colleagues until all interviews were held.  
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2.6 Data management 
Data collected with the facility assessment tool was directly converted into 
color-coded dashboards. 
The facility assessment data for the dispensaries was collected in Excel tables.  
Data collected with the KAP questionnaires was entered into an online RedCap 
database. Questionnaires were checked for completeness and consistency of 
available data was checked. Free text entries were converted into standardized 
categories. 
2.7 Statistical analysis 
The facility assessment data was analyzed manually and color-coded 
dashboards were elaborated. Colors were defined as follows: Infection control 
measures that were consistently observed or confirmed through documentation 
are marked green. Measures that were observed to be not in place are marked 
red. If a certain measure was reported to be practiced by the majority of staff 
and/or the head of the department, but could not be confirmed nor disproved 
during the time of assessment due to a lack of presumed TB cases, it was 
marked yellow. Measures that have been observed to be occasionally 
practiced, but not fully implemented or are only partly applicable are marked 
orange. 
The KAP survey data was extracted from the database and then checked for 
completeness and consistency in Excel tables. For statistical calculations IBM 
SPSS (Version 24) was used. Cross-tabulation was used to compare 
knowledge levels of different professional groups. In addition, mean scores 
within these professional groups were calculated. Further categorical variables 
were tested for influence on knowledge levels using Cross-tabulation and 
Fisher’s exact test. In order to avoid bias, doctors were excluded from these 
further analyses. Factors chosen to test for association with knowledge levels 
comprised sex, age, work experience, level of education, facility, family TB 
history and former training on TB.  
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Furthermore the influence of knowledge levels on infection control practices 
was determined. Therefore, the relative amount of items reported to be 
practiced was calculated for each participant.  The cut-off for defining “good 
practice” was set at 60%. Fisher’s exact test was used to test if good knowledge 
was a predictive factor of good practice.  
The significance level for this study was set at 0.05. 
2.8 Ethical aspects 
The study was approved by the institutional ethics committee of the CERMEL 
(Reference No. 008/2016, 29th October 2016) and was authorized by the 
regional health director of the Moyen-Ogooué province (Reference No. 
00458/MSPP/SG/DRSC, 14th November 2016).  
Written informed consent was obtained from all participants prior to the 
interviews. All KAP questionnaires were entirely anonymous as no names or 
other personal identifying information was recorded on the questionnaire. 
Informed consent forms and questionnaires were separately stored. 
In the end of the study, meetings with the participating hospitals and the 
regional health director were arranged to discuss the results, laying out a 
roadmap for further steps to improve TBIC. Briefing on the management of TB 
suspects and training sessions for staff was provided in order to ensure a direct 
benefit for the study facilities from the study results. 
Informational material such as brochures on TB and posters on cough hygiene 
were provided for the dispensaries.  
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3. Results 
3.1 Facility assessment 
3.1.1 Managerial controls 
The assessment revealed a general lack of managerial controls in all facilities. 
In none of the facilities there was a designated person in charge of infection 
control and there were no infection control committees. No facility had infection 
control guidelines and consequently no assessment of their implementation has 
been conducted. 
3.1.2 Administrative controls 
The state of implementation of administrative infection control measures in the 
respective facilities are presented in Table 2. The respective colors are 
explained in Table 1.  
No facility systematically screened patients for cough as they enter the facility. 
Presumed TB cases were reported to be prioritized in the ED of HAS and the 
CTA. However, both could not be confirmed during the assessment due to a 
lack of coughing patients.  
Presumed TB cases and TB patients were observed to be provided with 
surgical masks in the IM of CHRGR and HAS and partly in CHRGR’s OPD, 
where in some cases it was observed that patients were asked to wear a 
surgical mask by the consulting physician. Furthermore, this practice was 
reported but not confirmed in the ED of HAS and at the CTA. 
Presumed TB cases and TB patients were separated from other patients in the 
IM wards of CHRGR and HAS as well as the MT of CHRGR. In the PD of 
CHRGR isolation of presumed TB cases was reported and in HAS pediatric 
patients with TB were isolated if hospitalized, but not separated from others in 
the consultation waiting area. In all facilities sputum samples were either 
collected at home in case of ambulatory diagnostic or in isolation rooms, which 
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are separate from others but were only sufficiently ventilated in the MT of 
CHRGR. 
Newly diagnosed HIV-positive patients were systematically screened for TB by 
chest X-ray in the pediatric ward of HAS and the CTA. In both cases this was 
confirmed by reviewing patient files.  
Educational material for patients about TB was found only in the IM of HAS, 
where there were informational leaflets in the isolation rooms. No facility had 
posters instructing patients and visitors on cough hygiene.  
The MT of CHRGR screened all staff members for TB regularly by chest X-rays 
and sputum samples. In all facilities staff had access to confidential HIV 
counseling and testing on site. IPT for HIV-positive staff was available in none 
of the facilities. Initial training for new staff members on TBIC practices was 
reported to be provided for all personnel in the MT of CHRGR and was 
indicated by the head of the CTA, but was in both cases not documented. 
Table 1: Key 
 Not applicable 
 Not implemented 
 Sometimes done 
 Reported to be done by staff, but could not be confirmed 
 Implemented  
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3.1.3 Environmental controls 
Rooms were considered to be adequately ventilated if two openings on opposite 
walls and/or a fan leading the airflow out of a window and away from the HCW 
were implemented. 
Environmental control measures are presented in Table 3. In CHRGR, the 
OPD’s reception hall had high ceilings and was open to all sides and could thus 
be considered as well ventilated. Other waiting areas such as in front of the pay 
desk, the radiology or in front of the consultation rooms were not adequately 
ventilated, as there were no windows, low ceilings and ceiling fans were only 
partly used. In the consultation rooms windows were kept closed due to the 
usage of air conditioning (AC) and no fans were available. There was good 
cross-ventilation in the isolation rooms of the IM and the MT, as windows and 
doors on the opposite walls were kept open. At the IM ceiling fans were only 
used occasionally, whilst in the MT fans were observed to be consistently used 
during patient care; directing the airflow away from the HCW. The ED was not 
well ventilated, due to narrow hallways and no windows in many rooms. In the 
waiting area ceiling fans were used. The isolation room had one small window, 
no fans and the door remained closed. Isolation rooms of the PD where not 
adequately ventilated. 
In HAS there was good cross ventilation in the waiting areas of the polyclinic 
and the PD. Consultation rooms of the OPD and PD, the ED and isolation 
rooms of the IM and the PD were not adequately ventilated. Isolation rooms had 
one window and doors remained closed. In all consultation rooms and the ED 
windows were kept closed due to the use of AC. Ceilings were higher than 3 m 
in most areas of the facility. Only in the isolation room of the IM, ceilings were 
lower.  Fans were generally not available in this facility, except if brought by the 
patients themselves. Ceiling fans in waiting halls were out of order. 
The building structure of the CTA was not optimal for infection control of 
airborne diseases. There were no windows in the waiting area and thus no 
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cross ventilation. In consultation rooms ACs were used and windows closed. 
Ceilings were not higher than 3 m and no fans were used.  
3.1.4 PPE 
As presented in Table 4, adequate PPE was found in two departments only. In 
both cases the respirators were not provided by the facility itself. 
FFP3 masks were found to be regularly available at the MT of CHRGR. The 
masks were provided by the CERMEL and were observed to be consistently 
used by all personnel entering the respective unit. N95 respirators were found in 
the pediatric ward of HAS, but not on a regular basis and not provided by the 
hospital. In addition, they were not reported to be used frequently. In the CTA 
no adequate masks were available. 
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3.1.5 Patient flow 
As patient management in OPDs were found to be similar, in the following the 
patient flow at HAS is described exemplary. The flow of a presumed TB case 
through the facility is presented in Graph 2.  
At HAS, patients can either seek consultations at the OPD from Monday to 
Friday or present directly to the ED. Patients coming for outpatient consultation 
usually arrive from 7 a.m. onwards. After entering the facility, they register their 
name at the admission nurse in the waiting area. If they do not have an 
appointment, patients are sent to the triage office, where a nurse allocates them 
to a physician. If the patient is in a bad general health condition, he or she is 
referred to the ED. 
If the patient is insured by the Caisse Nationale d’Assurance Maladie et de 
Garantie Sociale (CNAMGS), the Gabonese public health insurance, he or she 
passes by the CNAMGS office, followed by the pay desk. When his documents 
and payments are processed, the cashier leaves the new patient file with the 
admission nurse, who then takes the patient’s vital parameters and gives him a 
number for consultation. Consultations begin approximately at 10 a.m., which 
means that there is a minimum of three hours waiting time for every patient.  
If the consulting physician suspects TB, the patient is sent for a chest X-ray, 
which is later evaluated by the same physician, either the same or the following 
day. If the radiology suggests a TB infection, the patient is hospitalized and 
sputum samples are earliest given the next day. After a positive result, 
treatment is initiated and the patient remains hospitalized for at least the first 10 
days of treatment. 
During the time of assessment, the number of patients seeking consultation 
exceeded the capacity of the physicians available.  
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Graph 2: Patient flow of a presumed TB case through the facility at the Albert 
Schweitzer Hospital  
*admission nurse takes vital parameters, CNAMGS: Caisse Nationale d’Assurance Maladie et 
de Garantie Sociale 
 
3.1.6 Other findings 
3.1.5.1 TB cases amongst staff 
In both hospitals cases of active TB among HCW were reported during 
interviews with the heads of department. The cases were not notified in an 
occupational health register and could consequently not be confirmed. One 
HCW developed active TB during the study period. 
In HAS two laboratory personnel were reported to have had developed TB in 
the past two years. One nurse of the ED developed active TB during the time of 
the study.  
The medical director of CHRGR reported two cases of active TB amongst two 
nurses from the maternity ward and the IM in the past 3 years. 
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In the CTA there were no known TB cases amongst staff. 
3.1.5.2 Documentation and archiving 
The review of documents such as patient files and TB registers revealed major 
deficiencies in documentation. Numbers were found to be inconsistent and 
registers were incomplete.  
All three facilities had a TB register. HAS reported to have a separate register 
for pediatric TB. However, the register was not found and thus not available for 
review.  
The IM of CHRGR used the official PNLT register, but data was incomplete. 
The TB register of HAS was handwritten and contained the following 
information: 
 patient file’s number 
 if the case was a new or known TB case 
 sputum smear microscopy result 
 HIV status 
The total number of TB cases in the year 2015 counted from both TB registers 
was inconsistent with numbers reported to the PNLT. None of the registers 
contained treatment outcomes. 
Patient files of TB cases from the last three months prior to assessment and at 
least the last five cases were reviewed. In all three facilities some of the files 
were not found. CHRGR was the only facility that kept laboratory results in all 
TB patient files. 
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3.1.6 Dispensaries 
In Table 5, all visited dispensaries in Lambaréné’s rural surroundings are listed. 
The total patient count for the past three months and the number and proportion 
of coughing patients amongst them as well as the number of staff working in 
each dispensary are also presented in Table 5. The number of patients visiting 
the facility in the past three months ranged from 206 to 1 253 for the 
dispensaries in Lambaréné and from 15 to 309 for the rural dispensaries. The 
proportion of coughing patients ranged from 6.8 % in the dispensary of Siat Zilé 
to 44.6 % in Paris-Bifoun with a median of 29 %.  
Eleven dispensaries were run by only one HCW, nine by assistant nurses and 
the dispensaries of the villages Adanhe and Tchad by an auxiliary nurse only, 
who are less trained than assistant nurses. In three dispensaries (Atsie, Isaac 
and Magnang) there was each one nurse qualified by a state’s diploma. The 
remaining personnel included further assistant and auxiliary nurses, cleaning 
staff, one intern, one vaccination agent and one technician.   
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Table 5: Baseline characteristics of the dispensaries  
 Total 
patients (N) 
Coughing 
patients (N) 
Proportion 
(%) 
Number of 
staff (N) 
Dispensary  
 
. . . . 
Urban Atsie 346 101 29,2 4 
Isaac 1253 238 19,0 5 
Magnang 210 44 21,0 6 
Moussamoukougou 
 
206 
 
61 
 
29,6 
 
1 
 
Rural Tchad 309 98 31,7 1 
 
Kery Paga 288 47 16,3 1 
Nombakélé 74 7 9,5 2 
Zilé St Martin 22 6 27,3 1 
Siat Zilé 236 16 6,8 2 
Nzoghe Bang 31 9 29,0 2 
Kongoulé 44 13 29,5 1 
Adanhe 15 3 20,0 1 
Medang Nkoghe 15 6 40,0 1 
Nkoghe Mboum 28 10 35,7 1 
Benguie 2 30 3 10,0 1 
Benguie 4 65 24 36,9 1 
Paris-Bifoun 121 54 44,6 2 
 
Infection control measures found in the dispensaries are presented in Table 6. 
There was no initial TBIC training provided for HCW. No dispensary had posters 
on cough hygiene, educational material or symptom checklists. In only one 
dispensary surgical masks were available and two dispensaries had enclosed 
waste baskets. Consultation rooms were adequately ventilated in six structures 
and windows were kept open during working hours in 13 dispensaries. Two 
urban dispensaries used fans in their consultation rooms. None of the facilities 
supervised TB treatment, i.e. there were no DOTs available. 
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3.2 KAP survey 
3.2.1 Demographics and TB history 
A total of 103 questionnaires were completed; 68 (66.0%) of the respondents 
were recruited at the two hospitals, 25 (24.3%) at dispensaries and 10 (9.7%) at 
the CTA. The interviews were conducted with eight auxiliary nurses, 58 
assistant nurses, 11 nurses with a state diploma, 10 doctors and 16 other 
personnel with frequent patient contact, such as cleaning staff, radiology 
technicians and psychologists. The mean work experience was 11.5 years, 
ranging from one month to 38 years. 
More than half of the respondents (59.2%) were female. The most frequent age 
categories were “31 - 40 years” and “41 - 50 years” with each 40 participants 
(38.8%), respectively, followed by the range “21-30 years” to which 13 
participants (12.6%) belonged to. Nine (8.7%) respondents were over 50 years 
old and only one younger than 20 years. 
While none of the participants reported to have had TB themselves, 44 (42.7%) 
said that they had already been tested for TB at least once. Almost all of the 
participants (99; 96.1%) reported having been vaccinated with the Bacille 
Calmette-Guérin (BCG) vaccine, and 36 (35.0%) said that one of their family 
members had suffered from TB. 
3.2.2 Knowledge 
3.2.2.1 Knowledge levels 
Knowledge levels according to profession are presented in Table 7. With a total 
of 42 respondents (40.8%), the largest part fell into the knowledge category 
“rather poor”, followed by “good” with 29 (28.2%) and “poor” with 22 (21.4%). 
Only 10 HCW (9.7%) had “Excellent” knowledge about TB.  
The majority of the auxiliary nurses (5/8, 62.5%) had poor knowledge, while a 
bit more than half of the assistant nurses (30/58, 51.7%) had “rather poor” 
knowledge. Five out of 11 nurses with a state diploma (45.5%) had good 
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knowledge, followed by “rather poor” (3/11, 27.3%). Two nurses had excellent 
knowledge. All of the ten doctors interviewed had good or excellent knowledge, 
three (30.0%) and seven (70.0%), respectively.  
 
The mean knowledge score out of the maximum score of 27 was 10 [95%CI: 
6.3;13.7] for auxiliary nurses, 14.2 [95%CI: 13.3;15.2] for assistant nurses, 17.7 
[95%CI: 15;20.5] for nurses, 22.4 [95%CI: 21.2;23.6] for doctors and 12.5 
[95%CI: 9.8;15.2] for other HCW. 
3.2.2.2 Specific knowledge 
The number and relative frequency of correct answers given to single-answer 
questions are presented in Table 8. Seventy HCW (68.0%) named the correct 
medical cause of TB and all respondents knew that TB is curable. The majority 
(83; 80.6%) knew the way of TB transmission, 75 (72.8%) knew the standard 
treatment and 74 (71.8%) the correct treatment duration. Only 57 participants 
(55.3%) thought that they could get TB despite being vaccinated with BCG. 
Almost all respondents (95; 92.2%) identified a connection between HIV and 
TB. However, only 66 HCW (64.1%) could explain the relationship between the 
Table 7: Knowledge levels by profession (n = 103) 
 Knowledge Levels Total 
Poor Rather 
poor 
Good Excellent 
Profession Auxiliary nurse 
N 5 2 1 0 8 
 % 62.5 25.0 12.5 0.0 100.0 
 
Assistant nurse 
N 11 30 16 1 58 
%  19.0 51.7 27.6 1.7 100.0 
Nurse 
N 1 3 5 2 11 
%  9.1 27.3 45.5 18.2 100.0 
Doctor 
N 0 0 3 7 10 
%  0.0 0.0 30.0 70.0 100.0 
Other 
N 5 7 4 0 16 
%  31.2 43.8 25.0 0.0 100.0 
Total 
N 22 42 29 10 103 
%  21.4 40.8 28.2 9.7 100.0 
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two diseases correctly. A minority (23, 22.3%) knew that sputum smear 
microscopy was the most frequently used diagnostic test for TB in Gabon. A bit 
more than half of the respondents (57; 55.3%) knew what MDR-TB is and 64 
(62.1%) thought that it is principally curable. 
 
Table 8: Number of correct answers to single answer questions (n = 103) 
 Correct N (%) 
What causes TB? 70 (68.0) 
Can TB be completely cured? 103 (100.0) 
How is TB transmitted? 83 (80.6) 
What is the standard treatment for TB? 75 (72.8) 
How long does the standard treatment for drug-sensitive  
pulmonary TB  usually take? 
74 (71.8) 
Can you get TB when you are vaccinated with BCG? 57 (55.3) 
Is there a relationship between HIV and TB? 95 (92.2) 
If yes, what is it? 66 (64.1) 
What is the most frequently used diagnostic laboratory test  
to diagnose TB in Gabon? 
23 (22.3) 
What is MDR-TB? 57 (55.3) 
Is MDR-TB curable? 64 (62.1) 
 
Table 9 shows the number and relative frequency of correct answers given to 
multiple answer questions other than about TB symptoms and risk factors.  
Almost half of the respondents (50; 48.5%) named the development of 
resistances as a consequence of incorrect TB treatment and 64 (62.1%) 
thought that the patient would relapse. Regarding the differences between LTBI 
and active TB, 27 HCW (26.2%) knew that in contrast to active TB disease, a 
latent infection is asymptomatic. Only one respondent stated in this context that 
LTBI is not contagious.  
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As possible infection control measures when being in the same room with a TB 
patient, HCW named measures aiming to increase the airflow and measures of 
cough hygiene with 29 (28.2%) each. Almost all respondents (98; 95.1%) knew 
that wearing a respirator would protect them from being infected.  
 
Table 9: Number of correct answers given to multiple answer questions (n = 103) 
 Correct N (%) 
What can happen if you take your TB drugs incorrectly/ disrupt TB 
treatment?  
  
Development of resistances 50 (48.5) 
Relapse 
 
64 (62.1) 
What is the difference between latent TB infection and TB disease?   
TB infection is asymptomatic 27 (26.2) 
TB infection is not contagious 
 
1 (1.0) 
When you are in the same room with a TB-infected patient, how can 
you minimize the risk of getting TB from that patient? 
  
Increase airflow 29 (28.2) 
Let patient perform cough hygiene 29 (28.2) 
Wear respirator 98 (95.1) 
How can you get MDR-TB?    
Through infection from another person with MDR-TB 32 (31.1) 
Through incorrect treatment 54 (52.4) 
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Graph 3 shows the proportion of interviewed HCW who named the 5 major 
symptoms of active TB. “Cough” was named by 100 respondents (97.1%), 
followed by “fever” with 68.9% (71) and “weight loss” with 61.2% (63). “Bloody 
sputum” was named by 30 HCW (29.1%) and 22 (21.4%) named night sweats 
as a symptom of TB. 
 
 
Graph 3: Relative frequency of TB symptoms named by the respondents (multiple 
answers were possible, percentages do not add up to 100)   
 
The most frequently named risk factors and risk groups for TB are presented in 
Graph 4. Seven HCW (6.8%) did not know any risk factor for developing active 
TB. The most frequently named risk group was “young children“, which was 
mentioned by 44 respondents (42.7%), followed by “close contacts of a 
confirmed case“ and “healthcare workers“ with 40 (38.8%) each. HIV/AIDS was 
named as a risk factor by 26 interviewees (25.2%). Thirteen HCW (12.6%) 
mentioned “people smoking” as a risk factor. Less than 10% of the respondents 
named “people drinking alcohol” (7), “people with medical conditions that 
weaken the immune system” other than HIV (4), “drug users” (3) and “people 
under immunosuppressive therapy” (1). 
.  
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Graph 4: Relative frequency of risk factors for TB named by the respondents (multiple 
answers were possible, percentages do not add up to 100)   
 
3.2.2.3 Determinants of knowledge levels 
Since all doctors had good or excellent knowledge and given that they were 
unequally distributed in other subgroups, they were excluded from the following 
analyses. Fisher’s exact test was conducted to identify factors that influence the 
knowledge level of the remaining 93 HCW.  
Factors and their association with knowledge levels are presented in Table 10. 
Three factors were identified as significant determinants of knowledge levels: 
Level of education (p = 0.007), facility (p = 0.047) and former training on TB (p = 
<0.001). Age, sex, work experience and TB cases in the family were not shown 
to have a statistically significant influence on knowledge about TB. 
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Table 10: Determinants of knowledge levels of HCW other than doctors (n = 93) 
 
Knowledge Levels 
p-value 
Poor 
 (n = 22) 
Rather poor 
(n = 32) 
Good  
(n = 26) 
Excellent 
(n = 3) 
Age       0.273 
 <20 years  0 (0.0%) 1 (2.4%) 0 (0.0%) 0 (0.0%)  
21-30 years  3( 13.6%) 8 (19.0%) 1 (3.8%) 0 (0.0%)  
31-40 years  7 (31.8%) 12 (28.6%) 14 (53.8%) 2 (66.7%)  
41-50 years  12(54.5%) 16( 38.1%) 8 (30.8%) 1 (33.3%)  
>50 years  0 (0.0%) 5 (11.9%) 3 (11.5%) 0 (0.0%)  
Sex       0.535 
 F  17(77.3%) 25 (59.5%) 16 (61.5%) 2 (66.7%)  
 M  5 (22.7) 17 (40.5%) 10 (38.5%) 1 (33.3%)   
Level of education      0.007 
 CEP  5 (22.7%) 9 (21.4%) 0 (0.0%) 0 (0.0%)  
 BEPC  11 (50.0%) 28 (66.7%) 15 (57.7%) 2 (66.7%)  
 BAC  2 (9.1%) 3 (7.1%) 7 (26.9%) 1 (33.3%)  
 University   0 (0.0%) 2 (4.8%) 2 (7.7%) 0 (0.0%)  
 Other  4 (18.2%) 0 (0.0%) 2 (7.7%) 0 (0.0%)  
Facility       0.047 
 Hospital  12 (54.5%) 20 (71.4%) 23 (88.5%) 3 (100.0%)  
 Dispensary  10 (45.5%) 12 (28.6%) 3 (11.5%) 0 (0.0%)  
Work experience      0.148 
 ≤ 5 years  7 (31.8%) 12 (28.6%) 2 (7.7%) 1 (33.3%)  
 6-10 years  8 (36.4%) 8 (19.0%) 10 (38.5%) 1 (33.3%)  
 11-20 years  6 (27.3%) 16 (38.1%) 9 (34.6%) 0 (0.0%)  
 > 20 years  1 (4.5%) 6 (14.3%) 5 (19.2%) 1 (33.3%)  
Family TB       0.767 
 No  16 (72.7%) 25 (59.5%) 18 (69.2%) 2 (66.7%)  
 Yes  6 (27.3%) 17 (40.5%) 8 (30.8%) 1 (33.3%)  
TB training       <0.001 
 No  21 (95.5%) 25 (59.5%) 15 (57.7%) 0 (0.0%)  
 
Yes  1 (4.5%) 17 (40.5%) 11 (42.3%) 3 (100.0%)  
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3.2.3 Attitudes 
As presented in Table 11, 84 HCW (81.6%) thought they could get TB 
themselves and 75 (72.8%) said that they were scared of getting TB. For the 15 
respondents (14.6%) who thought that they could not get TB, the most 
frequently named reasons for this were vaccination (7/15, 46.7%) and the belief 
of not being exposed due to adequate precautions (4/15, 26.7%). Out of the 75 
respondents who were scared of getting TB, 35 (46.7%) named the severity of 
the disease as a reason, 21 (28.0%) the possibility of infecting a family member 
and 20 (26.7%) the treatment duration and/or side effects. Further named 
reasons were the potential fatality of the disease, the fear of social isolation and 
irreversible respiratory alterations. 
Most of the respondents (97, 94.3%) would continue to socialize with a friend, if 
he was infected with TB. However, with 91 respondents (88.3%), the majority 
would not share the same cutlery, plates and glasses with a family member 
suffering from TB.  A total of 65 HCW (63.1%) considered TB as a stigmatized 
disease. 
Almost all respondents (101, 98.1%) reported that they would like to learn more 
about TB and 100 HCW (97.1%) said that they would be willing to get tested for 
TB regularly. TB was considered as a major threat to Gabon’s public health by 
98 HCW (95.1%) and 101 (98.1%) thought that TB control in their region should 
be improved. The most frequently made suggestion on how to improve the 
regional TB control was “conducting awareness raising campaigns”, which was 
named by 70 HCW, followed by “intensified case finding”  (16) and “vaccination 
programs” (10). 
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Table 11: Attitudes (n = 103) 
 Yes No Not sure 
N (%) N (%) N (%) 
1. Do you think you could get TB? 84 (81.6) 15 (14.6) 4 (3.9) 
2. Are you scared of getting TB? 75 (72.8) 25 (24.3) 3 (2.9) 
3. Would you continue to socialize with your 
friend, if he was diagnosed with TB? 
97 (94.2) 3 (2.9) 3 (2.9) 
4. Would you share the same cutlery, plates 
and glasses with a family member, if he was 
infected with TB? 
11 (10.7) 91 (88.3) 1 (1.0) 
5. Would you say that TB is a stigmatized 
disease? 
65 (63.1) 33 (32.0) 5 (4.9) 
6. Would you like to learn more about TB? 101 (98.1) 1 (1.0) 1 (1.0) 
7. Would you be willing to get tested for TB 
regularly? 
100 (97.1) 2 (1.9) 1 (1.0) 
8. Do you feel TB is major threat to public 
health in Gabon? 
98 (95.1) 3 (2.9) 2 (1.9) 
9. Do you think there is a need of 
improvement in TB control in your region? 
101 (98.1) 1 (1.0) 1 (1.0) 
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3.2.4 Practices 
TB infection control practices that were reported to be practiced by the 
interviewed HCW are presented in Table 12. If no statement could be made 
about the practice because the applicable situation had not yet occurred to the 
HCW, it was marked as not applicable (NA). This was mostly the case in 
dispensaries with a very small patient count.  
Most HCW (82, 79.6%) reported to suspect TB if the patient has been coughing 
for month. Less than half of the respondents (50, 48.5%) said that they separate 
coughing patients from other patients. While 56 (54.4%) of the respondents 
wear a surgical mask when dealing with a coughing patient, 73 (70.9%) 
reported to wear a mask when dealing with a confirmed TB patient. About half 
of the respondents (53.4%) said that they provide coughing patients with a 
surgical mask. 
Environmental controls in terms of increasing the natural ventilation by opening 
windows and doors were reported to be practiced by 69 HCW (67%), while only 
16 (15.5%) would turn on a fan. Thirty-two (31.1%) respondents said that they 
prioritize coughing patients in comparison to other patients. Sixty-three (61.2%) 
HCW stated to give newly diagnosed TB patients information about their 
disease and 77 (74.8%) said that they instruct coughing patients on cough 
hygiene.  
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Table 12: TB infection control practices reported by HCW (n = 103) 
 practiced not practiced NA 
N (%) N (%) N (%) 
1. When a patient says he has been 
coughing for a month, I suspect TB 
 
82 (79.6) 21 (20.4) 0 (0.0) 
2. I seperate coughing patients from 
other patients 
 
50 (48.5) 46 (44.7) 7 (6.8) 
3. When I deal with a coughing 
patient I wear a mask 
 
56 (54.4) 47 (45.6) 0 (0.0) 
4. When I deal with a confirmed 
active TB patient, I wear a mask 
 
73 (70.9) 29 (28.2) 1 (1.0) 
5. I give patients who arrive with a 
cough a mask 
 
55 (53.4) 48 (46.6) 0 (0.0) 
6. When a TB patient is in the room, I 
open windows and doors to increase 
natural ventilation 
 
69 (67.0) 30 (29.1) 4 (3.9) 
7. When dealing with a TB patient, I 
turn on the fan to increase ventilation 
 
16 (15.5) 86 (83.5) 1 (1.0) 
8. When a patient arrives at my 
facility with a cough, I prioritize 
him/her in comparison to patients 
without cough 
 
32 (31.1) 59 (57.3) 12 (11.7) 
9. If a patient is newly diagnosed with 
TB, I give him/her information about 
his/her disease 
 
63 (61.2) 35 (34.0) 5 (4.9) 
10. I explain coughing patients how 
they can practice cough hygiene, in 
order to avoid infecting other people 
around them 
77 (74.8) 25 (24.3) 1 (1.0) 
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Table 13 shows practice categories by knowledge levels. According to the 
predefined cut-off at 60% of practiced items, a total of 46 HCW (44.7%) had 
“poor” practices whereas 57 (55.3%) had “good” practices. Fisher’s exact test 
showed no significant association between knowledge levels and practice (p = 
0.263). Consequently, good knowledge about TB was not statistically 
associated with good infection control practice.  
 
Table 13: Practice by knowledge levels 
 Practice  
 
 
Total 
Poor N (%) Good N (%) N (%) 
Knowledge Levels 
Poor 13 (28,3) 9 (15,8) 22 (21,4)  
Rather poor 20 (43,5)  22 (38,6) 42 (40,8) 
Good 10 (21,7) 19 (33,3) 29 (28,2) 
Excellent 3 (6,5) 7 (12,3) 10 (9,7) 
Total 46 (100) 57 (100) 103 (100) 
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4. Discussion 
4.1 Assessment findings and recommendations 
4.1.1 Managerial controls  
The study revealed that there is a complete absence of managerial TBIC 
measures in healthcare facilities in the Moyen-Ogooué province. This was an 
expected outcome, as there are yet no efforts for TBIC in Gabon on a national 
level. As stated by the WHO [37] and highlighted by Verkuijl and Middelkoop in 
their article about occupational tuberculosis prevention [49], managerial controls 
are the framework for all TBIC activities and are therefore an indispensable 
requirement for the successful implementation of TBIC measures in healthcare 
settings. The study results pose evidence for the urgent need of national and 
facility-specific guidelines as well as appropriate funding and human resources 
for their implementation. 
4.1.2 Administrative controls 
There were only a few administrative controls that could be observed to be 
consistently practiced in several departments, e.g. the provision of surgical 
masks for presumed TB cases and the separation of coughing patients from 
others. However, most measures were not systematically implemented.  
Particularly the triage of coughing patients, which is one of the key aspects of 
administrative TBIC, could not be observed at all. As active cough screening 
can increase the detection rate of active TB, it should be systematically done at 
hospital admission. In addition, the early identification of a presumed TB case 
allows the provision with a surgical mask and can help to decrease the spread 
of potentially infectious aerosols in the facility (see section 4.2.5).  
Except for informational leaflets on TB in the IM isolation rooms at HAS, there 
was no educational material provided for patients in any of the facilities. 
Educational materials such as posters on cough hygiene are easily available 
online and pose a non-costly measure to raise awareness about TB and 
address stigma.  
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Although all staff had access to free HIV testing and counseling, only the MT of 
CHRGR screened their personnel for TB regularly. Regarding the higher 
incidence of TB amongst HCW, frequent screening should be offered by the 
facility in order to detect potential TB infections in an early stage.  
4.1.3 Environmental controls 
Certain environmental TBIC measures, such as ceiling height or number of 
windows, depend on the facility’s architecture and can thus not be easily 
influenced. However, keeping windows open and using fans to create airflow 
away from HCW are additional measures that are non-costly but nevertheless 
effective [39]. Although these measures are feasible in almost every setting, 
they could not be observed frequently. Especially in consultation rooms 
windows were kept closed and no fans were used because of the use of AC, 
which leaves the consulting physician at high risk when receiving a potentially 
infectious TB patient.  
Environmental controls in the CTA were particularly inadequate due to the 
building structure. This is critical, given that most patients attending the facility 
are HIV positive and thus highly susceptible to TB infection as well as likely to 
be infectious themselves.  
The MT was the only department where it was ensured that doors and windows 
were kept open in isolation rooms and fans were strategically positioned to 
direct the air out of the window. These measures should be systematically 
implemented throughout the facility. Window stickers can help to raise 
awareness regarding these environmental controls. However, triage at the 
beginning of a patient’s way through the facility is vital to ensure that HCW 
know when they are receiving a presumed TB case and can react accordingly.  
4.1.4 PPE 
None of the facilities provided adequate PPE for their staff. It was observed that 
HCW wore surgical masks when dealing with presumed TB cases or TB 
patients, which is not protecting them sufficiently from TB transmission. There 
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are only very few systematic studies providing evidence for this assumption. 
One of them was conducted by Lindsley et al. using an aerosol exposure 
simulation model to systematically assess filtration efficiency of different types 
of PPE. They found that surgical masks showed a significantly higher aerosol 
particle penetration than respirators and are thus not suitable to protect an 
exposed HCW from cough-generated aerosols [50]. This is not only applicable 
to TB, but to many other airborne diseases such as influenza or measles. 
Particularly in radiology rooms, where all presumed TB cases enter and 
sufficient ventilation is often not achievable due to the enclosed environment, 
staff depends on adequate respirators as a protective measure. 
Not only a budget for PPE must be put in place, but also awareness needs to 
be raised to ensure the appropriate use of respirators. The misconception of 
surgical masks being protective was also found in a KAP survey in South Africa, 
where only 24.6% of the participating HCW knew that surgical masks do not 
protect them from TB [51]. This can possibly increase risky behavior and needs 
thus be addressed in training sessions.  
4.1.5 Optimizing the patient management regarding TBIC 
Triaging, i.e. integrating early TB screening and following TBIC measures into 
the regular patient flow can help to systematically apply TBIC in the daily routine 
work. Verkuijl and Middlekoop suggest a patient flow chart that focuses on the 
identification of presumed TB cases by screening for chronic cough, separating 
patients accordingly and prioritizing them for fast consultation and sputum 
collection in order to minimize their time spent in the facility [49]. This is in line 
with the WHO recommendations as well as with the FAST strategy.  
Most aspects of this triaging system could also be applied in facilities like HAS. 
The admission nurse could screen for chronic cough and already provide the 
patient with a surgical mask. The triage office should then ensure the 
prioritization of the patient, e.g. by labeling the patient file with a priority marker. 
As suggested by Verkuijl and Middlekoop, the first sputum sample should be 
collected directly after the consultation. This should also be implemented at 
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HAS, where the first sample is usually collected the following day, leading to 
delays in treatment initiation. However, there are a few aspects that might not 
be feasible in this particular setting. According to the triaging system mentioned 
above, TB patients should leave the facility on the same day pursuing 
ambulatory treatment. In Gabon, TB drugs are not easily available and transport 
to CDTs is often long and costly. Henceforth, the practice of hospitalizing TB 
patients for the first 10 days of anti-tuberculous treatment, as it is done in HAS, 
might be more suitable for this setting, as it ensures treatment surveillance for 
the first days. As DOTS is not yet available in Gabon, this might be a suitable 
alternative. Furthermore, most patients are no longer infectious after these 10 
days so that TB transmission within the community becomes less likely. 
Another strategy that was developed to improve the management of presumed 
TB cases and is closely linked to triaging procedures is the FAST strategy. 
Although it was specifically developed for limited-resource settings, its 
implementation is not fully feasible in Gabon, as it relies on the constant 
availability of Xpert® MTB/RIF assays. During the time of the study, this 
diagnostic tool was only available at the CERMEL for the Moyen-Ogooué 
province. In order to implement the FAST strategy effectively, funding is 
necessary to provide all CDTs with Xpert® machines.  
4.1.6 Other findings 
There were several TB cases amongst staff reported in in-depth interviews with 
the heads of the department. However, they could not be verified as they were 
not documented. In addition, the true incidence of TB amongst HCW in Gabon 
remains unknown and requires further investigation.  
Documentation of TB cases, TB patient files and registers were highly 
incomplete and inconsistent with the officially reported data. For better 
treatment surveillance and regarding the increasing drug-resistances, it is of 
paramount importance to fully document TB cases, diagnostic results and 
treatment outcomes. These findings indicate that TB reporting systems need to 
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be strengthened in to gain systematic data about the true burden of TB in 
Gabon. 
4.1.7 Dispensaries 
Although dispensaries are not authorized to treat TB in Gabon, they must be 
able to recognize presumed cases and refer them to a diagnostic center. In 
most dispensaries nearly a third of the patients presented with cough as one 
their main symptoms (see table 3). Thus, it can be assumed that there is a 
considerable number of TB infected patients seeking consultation in 
dispensaries. More than half of the dispensaries were run by a single assistant 
or auxiliary nurse, who is usually not adequately trained to identify presumed TB 
cases.  
Due to their proximity to the communities dispensaries also play a central role in 
patient education. Considering this, dispensaries were found to be extremely 
insufficiently equipped. None of them had informational material on TB or 
posters on cough hygiene and only two facilities had enclosed waste baskets. 
Only one dispensary had surgical masks available. They should be able to 
provide coughing presumed TB cases with surgical masks in order to protect 
themselves as well as others during the transport to the next diagnostic center 
in Lambaréné. 
Regarding TBIC, however, the dispensaries had one advantage: In contrast to 
the larger facilities, environmental controls in terms of natural ventilation were 
found to be adequate in many of the dispensaries. There was cross-ventilation 
in 6 facilities and 13 facilities constantly kept their windows open during working 
hours. Mechanical ventilation was only found in two urban dispensaries in 
Lambaréné, as there was no electricity in rural areas. 
Ideally, dispensaries should be integrated in TB treatment surveillance, which 
would be in line with the DOTS strategy. As the Panepi study in Lambaréné 
showed, high transport costs to the urban hospitals were one of the main 
reasons why patients abandoned their TB treatment [22]. This implies that 
primary health services must not be neglected in general TB control. 
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4.2 KAP survey findings 
4.2.1 Knowledge levels 
The survey allowed deep insight into regional HCWs’ knowledge and 
awareness levels towards different aspects of TB. It serves as an orientation for 
future training programs and provides background information on general TB 
management.  
Two-fifth of the participants fell into the knowledge category “rather poor”, which 
suggests that HCW in the Moyen-Ogooué province are not adequately trained 
regarding TB and TBIC. While nurses with a state diploma and doctors had 
overall high knowledge levels, the majority of assistant and auxiliary nurses fell 
into the categories “rather poor” and “poor”. Considering that assistant nurses 
represent the largest part of HCW in the Moyen-Ogooué province and well-
trained personnel such as nurses and doctors are rather rare, the survey 
findings suggest that training programs should focus on HCW with a lower 
professional degree.  
4.2.2 Knowledge gaps 
Overall basic knowledge about TB transmission and treatment was good. 
However, the survey revealed several knowledge gaps. Almost half of the 
respondents erroneously thought that they could not get TB when being 
vaccinated with BCG, a belief that was also found amongst 41% of the nurses 
and 9% of the doctors in a KAP survey conducted at two university hospitals in 
Ethiopia [52]. Only 22.3% of the HCW knew that sputum smear microscopy is 
the most frequently used diagnostic test for TB in Gabon. Whereas nearly all 
HCW named “cough” as an indicator of TB, only 21.4% knew that “night sweats” 
were also a typical symptom. Basic knowledge about symptoms and 
diagnostics of TB are crucial to identify presumed TB cases. A lack of suspicion 
can lead to delays in diagnosis and treatment initiation and therefore contribute 
to the spread of TB in the community. This is why all HCW should be sensitized 
and trained to recognize possible TB cases early.  
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Moreover, the majority did not know what LTBI was; 26.2% knew that LTBI is 
asymptomatic and only one HCW mentioned in this context that LTBI is not 
contagious. Furthermore, there were signs that could indicate a lack of 
awareness towards the problem of increasing drug resistance. Merely a bit less 
than half of the participants named “development of resistance” as a 
consequence of incorrect treatment. In addition, only 55.3% of the participants 
knew what MDR-TB was. 
Regarding TBIC measures, with 95.1% almost all HCW knew that wearing a 
respirator when with a TB patient would protect them from becoming infected. 
However, in this context it can be assumed that the respondents were referring 
to surgical masks and not particular respirators. Other measures as increasing 
the ventilation e.g. by opening windows or ensuring that the patient is provided 
with a surgical mask were named by less than a third of the respondents only.  
For effective case finding strategies, the knowledge of groups who are 
particularly vulnerable to TB is of paramount importance. The majority of the 
survey respondents were able to name several risk factors for TB. Young 
children were the most frequently named risk group for TB. This might be 
attributed to the idea that children are generally a vulnerable group for infectious 
diseases. The second most named groups were HCW and contact cases, which 
shows that participants were well aware of the risk of exposure. However, HIV-
infection, as one of the most relevant risk factors in this setting, was named by 
25.2% only. This might indicate a lack of awareness amongst HCW towards the 
high co-infection rates in Gabon and the difficulties regarding the control of 
these synergistically acting diseases. In addition, the survey showed that the 
majority of HCW knew that there is a relationship between HIV and TB, but only 
64.1% could correctly explain this association. 
These findings contribute to the understanding of awareness levels regarding 
TB amongst HCW in Moyen-Ogooué and can help to plan specific training 
programs. These should focus on topics where knowledge was found to be 
rather poor amongst the participants, such as LTBI and MDR-TB. In addition, 
awareness should be raised towards the role of HIV-infection and TB.  
65 
 
4.2.3 Factors associated with good knowledge 
Besides the profession, there were several factors identified that are 
significantly associated with knowledge levels. Whereas work experience was 
not found to have an influence on knowledge about TB (p = 0.148), former TB 
training was a highly statistically significant determinant of good knowledge 
levels (p = < 0,001). This reinforces the assumption that training of staff has a 
sustainable effect on their awareness towards certain diseases and should 
therefore be provided for all HCW. Another determinant identified was the 
highest level of education (p = 0.007), which can be attributed to the association 
with the profession. In addition, it was found that HCW in hospitals had better 
knowledge about TB than in dispensaries (p = 0.047). This indicates that HCW 
in primary healthcare services must not be forgotten and should be included in 
training programs.  
4.2.4 Attitudes 
While attitudes towards TB were generally positive and almost all (94.2%) of the 
HCW would continue to socialize with a TB infected friend, 88.3% of the 
participants would not share the same cutlery, plates and glasses with a TB 
infected family member. This possibly indicates misconceptions about TB 
transmission, which could contribute to the stigmatization of TB infected 
individuals. The idea of TB being transmitted through eating from the same 
plate was also found amongst the general population in Cameroon [53] and 
thus seems to be a common belief.  
TB was considered as a stigmatizing disease by 63.1% of the HCW. This 
finding is in line with the perception of the 30 TB patients who were interviewed 
in Lambaréné in 2013, as 67% considered their disease as problematic with 
regard to stigma [54]. 
Almost all respondents said that they would like to learn more about TB and 
would also be willing to get themselves tested regularly. In addition, the majority 
considered TB as a major threat to Gabon’s public health and thought that TB 
control must be improved in their region. Furthermore, more than two-thirds of 
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the participants said that they are scared of getting TB. These findings show 
that HCW are aware of TB being a serious public health problem in Gabon and 
imply that they would be open for new policies and training programs.  
4.2.5 Good Practice  
Practices reported in the survey did not imply reasons why certain measures 
were done or not done. Henceforth it could not be concluded if poor TBIC 
practice resulted from a lack of awareness or inadequate facility structures and 
equipment. For example, in some departments such as the ED at HAS there 
were no isolation rooms available and henceforth coughing patients could not 
be separated from others even though HCW were aware of the risk of 
transmission. This might explain why less than half of the HCW separate 
coughing patients from others. 
Only 53.4% of the respondents said that they provide coughing patients with 
surgical masks. This is partly attributed to the unavailability of masks in 
dispensaries, but could also indicate fear of encouraging the stigmatization of 
patients. The same reasons could possibly explain why only a bit more than half 
of the HCW reported to wear a mask themselves when receiving a coughing 
patient. However, this could not be concluded from the survey findings and 
needs further qualitative research.  
Another rather rarely practiced TBIC measure was the prioritization of coughing 
patients, which was reported to be practiced by about a third of the 
respondents. This is in line with the observations made during the assessment 
and shows that TBIC is not yet implemented into the daily activities. 
Furthermore, it could be attributed to a lack of awareness towards the fact that 
minimizing the time spend in the facility can reduce the risk of nosocomial 
transmission. 
With 15.5%, only a minority reported to turn on a fan when dealing with a TB 
patient. This can be explained by the absence of fans in most facilities. In 
addition, only about two-thirds of the respondents said that they would open 
windows and doors to increase natural ventilation when being with a TB patient. 
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These findings might indicate a lack of awareness towards environmental TBIC 
measures and should be included in TBIC training of HCW.  
Good knowledge about TB was not found to be statistically associated with 
good practice (p = 0.263). This suggests that good TBIC practice does not only 
depend on good knowledge about TB, but also on the facility structure, 
feasibility regarding manpower and adequate equipment. 
These results stand in contrast to findings in a South African study, where good 
knowledge was found to be a significant predictor of good practice. This might 
be explained by the different methodology, as only knowledge about TBIC in 
particular was measured [51]. However, there is another similar study, which 
was conducted in Ethiopia and showed that there was no association between 
knowledge and practice [55].   
4.3 Strengths and limitations of the methods 
4.3.1 Assessment method and presentation of the results 
The standardized facility assessment tool was very comprehensive and 
therefore captured many aspects of TBIC and general TB management. 
However, it turned out to be not fully suitable regarding the setting. In order to 
be more specific, it had to be adjusted during the study, leading to a 
combination of quantitative and qualitative data. In addition, the observational 
character of the study contributed to more qualitative data. A new tool was 
elaborated accordingly and can be used in future studies. It includes distinct 
instructions on the conduction of the assessment and thus ensures comparable 
data.   
A limitation of the study was that the duration of the assessment of two to three 
days per department was sometimes not long enough to observe the 
management of (presumed) TB cases, due to a lack of cases. Consequently, 
certain measures could not be determined. This needs to be taken into 
consideration for future assessments. 
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In this study, openings on opposite walls were used as an indicator for 
adequate ventilation. This poses only an estimate and needs to be verified with 
quantitative methods e.g. measuring carbon dioxide concentration and 
calculating the risk of transmission as proposed by Rudnick and Milton [56].  
By choosing color-coded dashboards for the presentation of the results, the aim 
was to provide a general overview of the current state of implementation of 
TBIC measures. This allows easy comparison of the baseline results to future 
follow-up data once an implementation process is initiated, as it was done e.g. 
by Dokubo et al. in Nigeria [57]. 
4.3.2 KAP survey  
The professional categories amongst the participants were unequally distributed 
with more than half of the study population being represented by assistant 
nurses. This, however, reflects the contribution of professions amongst medical 
staff that was observed in the study and could thus be regarded as 
representative for HCW in the Moyen-Ogooué province. 
Although the participation rate was generally high, a few HCW refused to sign 
the informed consent form und could thus not be included in the survey. Oral 
informed consent with anonymous questionnaires might be taken into 
consideration for future surveys.  
By asking the KAP questionnaire in personal interviews, it could be ensured that 
the questions were clearly understood. In addition, participants did not skip any 
questions, as it might have been the case in self-administered questionnaires. 
However, response bias could not be completely excluded.  
Another strength of the study was that questions in the survey were asked 
openly, in order to avoid respondents guessing the correct answer. In contrast 
to self-administered questionnaires, this aimed to test the awareness level and 
not passive knowledge. On the contrary, this might have lead to inconsistencies 
between answers, which could not be explained and need further investigation. 
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Practices reported in the survey were partly inconsistent with observations 
made during the assessment. This discrepancy could possibly be due to a 
social desirability bias, which could not be completely eliminated. A limitation of 
the study was that reasons for these discrepancies could not be evaluated. 
More qualitative research is necessary to explain why theoretical knowledge 
was sometimes not put into practice. 
4.4 Conclusions 
The observed lack of well implemented infection control measures poses 
evidence for the urgent need of national TBIC guidelines, including an 
appropriate budget and human resources for their implementation. The claim 
that HCW are not sufficiently protected from TB transmission was highlighted by 
the fact that in both hospitals, there were each two cases reported amongst 
staff and one further case was observed during the study period. The interviews 
revealed that HCW were aware of this risk, as 72.8% stated to be scared of 
getting TB and with 98.1%, almost all survey participants thought that there was 
a need of improvement in TB control in their region. In addition, HCW were 
amongst the most frequently named risk groups for TB. Regular screening 
procedures should be put in place for all personnel, as it was done in only one 
out of a total of 10 individual departments and in none of the dispensaries. As it 
was shown in the KAP survey, the majority of HCW (97.1%) would approve 
being tested for TB regularly. 
Although there was no association found between good knowledge and good 
TBIC practice, it can be assumed that basic knowledge about TB is the basis for 
understanding and performing TBIC adequately. The rather low knowledge 
levels found among the interviewed HCW empathizes the need of specific TB 
training. Assistant nurses presented the largest part of HCW in the respective 
facilities, but only less than a third (29.3%) had good or excellent knowledge 
and more than half of them (51.7%) fell into the category “rather poor”.  On the 
contrary, 70% of the doctors participating in the survey had excellent and 30% 
good knowledge. These findings indicate that special attention should be paid to 
assistant nurses in training activities.  
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There was evidence of common misconceptions about TB, e.g. the fact that 
44.7% thought that they could not get TB when being vaccinated with BCG 
vaccine. This was, however, inconsistent with the finding that 81.6% thought 
that they could get TB themselves, given that almost all respondents reported to 
be vaccinated with BCG. Nevertheless, there were still 14.6% who 
demonstrably stated that they did not think that they could be infected with TB, 
out of which 46.7% saw the BCG vaccine as the reason for this. Such 
misconceptions could possibly hinder HCW from adequately practicing TBIC 
In addition, the KAP survey findings indicate a lack of awareness towards the 
vulnerability of HIV infected people to TB. This could possibly explain why only 
2 out of 10 individual departments screened newly diagnosed HIV-positive 
patients for TB.  
Some reported TBIC practices can be attributed to inadequate structural 
conditions.  The facility assessment identified structural obstacles such as the 
unavailability of surgical masks and fans in dispensaries as well as the lack of 
isolation rooms in hospitals. This is in line with low practice rates reported in the 
survey. However, further investigations such as focus group discussions are 
necessary to understand further obstacles that might hinder HCW from 
successful TBIC. 
4.5 Prospects 
The study results indicate that HCW in the Moyen-Ogooué province are 
insufficiently protected from TB infection. Efforts have to be made to improve 
TBIC and general knowledge about TB amongst HCW.  
Prior to other activities, guidelines have to be established on a national level in 
collaboration with the PNLT. These guidelines need to be specifically adjusted 
for each healthcare structure, followed by regular monitoring assessments. As 
Emerson et al. showed in their longitudinal study in Zambia and Botswana, a 
facility-specific plan and training of HCW can considerably improve the TBIC 
performance of a clinic within one year [58]. Another prerequisite for the 
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successful implementation of these guidelines are adequate manpower and 
financing.  
Once the implementation is in progress, focus group discussions have been 
proven beneficial to identify obstacles in the implementation process. 
Frequently named obstacles that were found in other studies included 
inadequate structures, lack of manpower and managerial support as well as 
stigma [59, 60]. 
As the KAP survey revealed, knowledge about TB was rather poor, especially 
amongst auxiliary and assistant nurses who present the largest part of HCW in 
the Moyen-Ogooué province, particularly in rural areas. As good basic 
knowledge is vital for effective TB control, training sessions need to be initiated 
with focus on these groups in order to raise awareness, eliminate misbelieves 
and fight against the stigmatization of TB patients.  
Due to their proximity to the communities, primary healthcare services play a 
crucial role in TB control and should therefore not be forgotten. In the future, the 
PNLT should make efforts to integrate dispensaries into TB care and 
educational programs as it is also part of the DOTS strategy.  
The results of this study pose evidence for gaps regarding the current TBIC 
situation in the Moyen-Ogooué province and aim to serve as a starting point for 
initiating a change in local TB control. More operational research will be 
necessary in the future to eventually maximize the protection of HCW and other 
patients from nosocomial TB transmission. 
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5. Summary  
 
Background: Due to their interaction with infectious TB patients, HCW are at 
greater risk to develop TB than the general population. TB transmission in 
healthcare settings does not only threaten HCW, but also other patients and 
visitors in the hospital. Although Gabon ranks among the top-ten high incidence 
countries in the world, there are currently no national guidelines available for 
TBIC and several TB cases have already been notified among HCW. In the 
Moyen-Ogooué province, where resources are limited and evidence of a high 
MDR-TB prevalence is accumulating, effective TB control remains a challenge. 
The aim of this study was to assess the current TBIC practices in different 
healthcare facilities in the Moyen-Ogooué province and to provide insight into 
the knowledge, attitude and practices of HCW regarding TB.  
Methods: Twenty healthcare facilities, including two hospitals, one ambulatory 
HIV-clinic and 17 dispensaries, were assessed using a standardized tool. The 
assessments were conducted by direct observation, reviewing documents and 
in-depth interviews with the head of the facility or department. Current TBIC 
practices in the Moyen-Ogooué province were evaluated in comparison to the 
WHO recommendations on TBIC in healthcare facilities in limited-resource 
settings. In addition, the knowledge, attitude and practices of HCW were 
investigated by means of an interviewer-administered questionnaire which was 
particularly designed for this study.  
Results: The study revealed a complete absence of managerial TBIC controls 
such as infection control guidelines or committees. The implementation of 
administrative and environmental control measures was generally low. The 
MDR-TB department of one of the assessed hospitals was the only department 
that provided regular TB screening for its personnel. 
A total of 103 KAP survey questionnaires were completed by HCW. According 
to predefined categories, 40.8% of the respondents had “rather poor” 
knowledge about TB. However, all doctors had “good” or “excellent” knowledge. 
The professional category, level of education and former training on TB were 
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found to be significantly associated with good knowledge levels. Attitudes 
towards TB and TBIC were overall positive. With 72.8%, the majority of HCW 
was scared of getting TB and 97.1% would be willing to be screened for TB 
regularly. Reported TBIC practice rates were rather low, especially regarding 
triaging of presumed TB cases and environmental controls. Good knowledge 
about TB was not statistically associated with good TBIC practice. 
Conclusions: The study results provided evidence for the urgent need of 
national TBIC guidelines, as HCW in the Moyen-Ogooué province are not 
sufficiently protected from occupational TB transmission. The assessment 
results can serve as a reference point for elaborating feasible guidelines and 
monitoring their implementation. The KAP survey results suggest, that effective 
TBIC does not only depend on good knowledge about TB, but also requires 
adequate facility structures, manpower and financing. However, particularly 
HCW with a lower professional degree, who represent the peripheral healthcare 
system, must receive training on TB and TBIC, as basic knowledge about TB is 
crucial for the early identification of TB patients.  
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6. Summary in German language  
 
Hintergrund: Aufgrund ihrer Interaktion mit infektiösen Tuberkulosepatienten 
haben Beschäftigte des Gesundheitswesens ein höheres Risiko eine 
Tuberkulose zu entwickeln, als die allgemeine Bevölkerung. Die 
Tuberkuloseübertragung in Gesundheitseinrichtungen gefährdet nicht nur die 
Mitarbeiter, sondern auch andere Patienten und Besucher. Obwohl Gabun zu 
den zehn Ländern mit der höchsten Tuberkuloseinzidenz weltweit zählt, gibt es 
zurzeit keine nationalen Leitlinien für deren Infektionskontrolle und es wurde 
bereits über mehrere Tuberkulose-Fälle unter Beschäftigten des 
Gesundheitswesens berichtet. In der Moyen-Ogooué Provinz, wo Ressourcen 
beschränkt sind und es immer mehr Hinweise auf eine hohe MDR-TB-
Prävalenz gibt, ist eine effektive Infektionsprävention der Tuberkulose weiterhin 
eine Herausforderung. Das Ziel dieser Studie war es, die aktuellen 
Infektionskontrollmaßnahmen in verschiedenen Gesundheitseinrichtungen der 
Moyen-Ogooué Provinz zu erfassen und einen Einblick in das Wissen und die 
Haltung des Personals, sowie Anwendung von Präventionsmaßnahmen 
bezüglich der Tuberkulose von Mitarbeitern des Gesundheitswesens zu 
gewinnen. 
Methoden: Mithilfe eines standardisierten Fragebogen wurden insgesamt 20 
Gesundheitseinrichtungen beurteilt, einschließlich zweier Krankenhäuser, einer 
ambulanten HIV-Klinik und 17 sogenannter „dispensaires“ (periphere 
Gesundheitseinrichtungen, in welchen vor allem Krankenpfleger und 
Krankenpflegerinnen Patienten medikamentös behandeln). Die Beurteilung der 
Gesundheitseinrichtungen erfolgte durch direkte Beobachtung, Überprüfung 
von Dokumenten und Tiefeninterviews mit den Leitern der Einrichtung bzw. der 
Abteilung. Die aktuell praktizierten Infektionskontrollmaßnahmen bezüglich der 
Tuberkulose wurden im Vergleich zu den Empfehlungen der WHO zur 
Tuberkulose-Infektionskontrolle in Gesundheitseinrichtungen unter 
ressourcenlimitierten Verhältnissen evaluiert. Außerdem wurden mithilfe eines 
Interviewer-gestützten Fragebogens, welcher speziell für diese Studien 
entwickelt wurde, das Wissen der Mitarbeiter mit Patientenkontakt  über die 
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Tuberkulose, deren Einstellung zu der Erkrankung und deren derzeit 
ausgeübten Präventionsmaßnahmen erfasst. 
Ergebnisse: Die Studie zeigte einen generellen Mangel an 
aufbauorganisatorischen Infektionskontrollmaßnahmen wie entsprechenden 
Leitlinien oder Ausschüsse. Die Umsetzung von administrativen Maßnahmen 
und adäquaten Umweltbedingungen war allgemein unzureichend. Die Station 
für MDR-TB war die einzige Abteilung, welche Personal regelmäßig auf 
Tuberkuloseinfektionen untersuchte.  
Insgesamt nahmen 103 Beschäftige des Gesundheitswesens an der Umfrage 
teil. Gemäß den zuvor definierten Kategorien, hatten 40,8% der Teilnehmer 
„eher schlechte“ allgemeine Kenntnisse über die Tuberkulose. Alle 
teilnehmenden Ärzte dagegen hatten „gutes“ oder „exzellentes“ Wissen. Es 
stellte sich heraus, dass die Berufsgruppe, der Bildungsgrad sowie vorherige 
Fortbildungen über Tuberkulose signifikant mit gutem Wissen assoziiert waren. 
Einstellungen gegenüber der Tuberkulose und 
Infektionspräventionsmaßnahmen waren alles in allem positiv. Mit 72,8% hatte 
die Mehrheit der Befragen Angst sich mit Tuberkulose zu infizieren und 97,1% 
wären einverstanden sich regelmäßig testen zu lassen. Nach eigenen Angaben 
wurden eher wenige Infektionspräventionsmaßnahmen ausgeübt, vor allem 
bezüglich der Triage von eventuellen Tuberkulosefällen und 
Umweltmaßnahmen. Gutes Wissen über Tuberkulose stand statistisch in 
keinem Zusammenhang mit der konsequenten Ausübung jener Maßnahmen.  
Schlussfolgerungen: Die Studie lieferte den Beweis für eine dringende 
Notwendigkeit für nationale Tuberkulose-Infektionskontrollleitlinien, da die 
Beschäftigten des Gesundheitsweisens in der Moyen-Ogooué Provinz nicht 
ausreichend vor berufsbedingter Tuberkuloseübertragung geschützt sind. Die 
Ergebnisse der Beurteilungen der Gesundheitseinrichtungen können dabei als 
Orientierung für die Entwicklung solcher Leitlinien dienen, Aufschluss über 
deren Umsetzbarkeit geben und helfen, den Implementierungsprozess zu 
überwachen. Die Umfrageergebnisse deuten darauf hin, dass erfolgreiche 
Tuberkulose-Infektionsprävention nicht nur von guten Kenntnissen über die 
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Erkrankung abhängt, sondern außerdem adäquate Gebäudestrukturen, 
Personal und Finanzierung braucht. Trotzdem müssen insbesondere Mitarbeiter 
mit einem niedrigeren Ausbildungsgrad in Fortbildungen über Tuberkulose und 
die entsprechenden Präventionsmaßnahmen eingebunden werden, da 
allgemeines Wissen über Tuberkulose entscheidend für die rechtzeitige 
Identifizierung von Tuberkulosepatienten ist. 
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Annex 1: Facility assessment tool 
 
TB-ICE – Facility Assessment 
Assessed by: __________________________________  Date: ___________ 
Facility: _____________________________________________________________ 
Person in charge of infection control or equivalent: 
_____________________________________________________________________ 
 
 
 1. Managerial controls: Supporting structures and activities to ensure 
implementation of TB infection control interventions 
 
If initial training about TB is provided for new staff members, 
what groups of employees are included in this training? 
   
        
        
    
 
 
  
 0 1 2 NA 
1.1. Does your facility have an Infection prevention and 
Control Committee? 
No  Yes NA 
1.2. Did this committee meet within the last 4 weeks? No  Yes NA 
1.3. Is there a written TB Infection Control Plan for the 
facility? 
No Yes (not 
kept on site) 
Yes 
(kept on 
site) 
NA 
1.4. Is the TB infection control plan displayed in (a) public 
place? 
No  Yes NA 
1.5. Were TB infection control measures assessed 
internally within the last 5 weeks? 
No  Yes NA 
1.6. Were staff trained in TB infection control this month? No Some staff Yes NA 
1.7. Is initial training provided for new staff members about 
TB infection control practices? 
No Some staff Yes NA 
1.8. Were all newly diagnosed HIV+ clients screened for 
TB symptoms (cough, loss of weight, night sweat)? 
Some 
(no 
proof) 
Some 
(proof 
available) 
Yes 
(proof 
availabl
e) 
NA 
1.9. Were any maintenance activities undertaken during 
the last 4 weeks on structures, which improve TB infection 
control (e.g. air conditioning, fans, ultraviolet germicidal 
irradiation (UVGI))? 
No  Yes NA 
Max. total score = 18  
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Is ongoing training provided for health care workers about TB 
infection control practices? 
□ Yes □ No 
    
If YES, what groups of employees are included in the training? 
   
        
        
    
How often is training done? 
______________________________________________________________________ 
 
    
Is it mandatory? 
 
□ Yes □ No 
    
Are records kept of training sessions? 
 
□ Yes □ No 
    
If YES, review documentation of when trainings were held and who attended the 
trainings and summarize below. 
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2. Patient Education and Awareness 
 0 1 2 NA 
2.1. Are posters displaying cough hygiene prominently 
displayed? 
No  Yes NA 
2.2. Are TB suspects/patients taught about cough etiquette 
and respiratory hygiene? 
No Occasionally Yes NA 
2.3. Are patients given educational materials on TB? No Occasionally Yes NA 
2.4. Are patients taught about signs and symptoms of TB? No Occasionally Yes NA 
Max. total score = 8  
 
If patients are given educational materials on TB, describe the 
materials and keep a copy for review.     
        
        
 
If patients are educated about signs and symptoms of TB, 
where, how often, and by whom?    
        
        
        
 
If patients are taught about cough etiquette and respiratory 
hygiene, where, how often, and by whom?    
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3. Administrative controls: Strategies to reduce generation of infectious  
 aerosols: 
 
If a TB suspect register is available, record the following numbers for the 
previous calendar year (2015): 
How many presumed TB cases were identified? 
  
  
How many TB suspects had sputum smear/Xpert sent? 
  
  
How many TB suspects had sputum culture sent? 
  
  
For how many TB suspects were smear/Xpert results available? 
  
  
For how many TB suspects were culture results available? 
  
  
How many TB suspects had a positive smear /Xpert? 
  
  
How many TB suspects had a positive culture? 
  
  
How many suspects with positive smears were started on TB 
treatment?   
  
How many suspects with positive cultures were started on TB 
treatment?   
  
    
What was the total adult headcount (patient-visits) for the clinic? 
  
  
    
  
 0 1 2 NA 
3.1. Are patients screened for cough as they enter your 
facility? 
No Occasionally Yes NA 
3.2. Is there a symptom checklist in place to screen 
patients for TB? 
No  Yes NA 
3.3. Are patients educated in cough hygiene as they enter 
your facility?  
No Occasionally Yes NA 
3.4. If patients cough, are they provided with 
masks/tissues to reduce infectious aerosols? 
No Occasionally Yes NA 
3.5. Is there an enclosed waste basket where tissues and 
face masks can be discarded? 
No  Yes NA 
3.6. Are TB suspects/patients separated from those who 
are not? 
No Occasionally Yes NA 
3.7. Are TB suspects given priority to ensure shorter 
waiting times in outpatient facilities? 
No Occasionally Yes NA 
3.8. Were staff reminded of the need for ‘early TB 
diagnosis’ during this month? 
No  Yes NA 
3.9. Are there separate and ventilated facilities for sputum 
collection from suspects? 
No Yes, but not 
ventilated 
Yes NA 
3.10. Is there a ‘fast queue’ for collection of sputum smear 
results? 
No  Yes NA 
3.11. What is the laboratory turn-around time for sputum 
AFB/microscopy for the last sputum AFB result received? 
> 72 
hours 
48-72 hours < 48 
hours 
NA 
Max. total score = 22  
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How are TB suspects evaluated? Observe consultations and describe in as 
much detail as possible (include details on route and time between entry to 
evaluation, including sputum collection, to departure): 
        
        
        
 
 
Where are sputum specimens kept? 
   
        
        
    
Is there a specimen tracking system? 
 
□ Yes □ No 
 
    
Review the charts for 5 TB patients seen in the last 3 months to 
determine the # days between sputum collection and initiating TB 
treatment.  
Date 
sputum 
collected 
Date 
result 
received 
Date 
treatment 
started 
Patient # 1 
………………………………………………………………………… 
      
Patient # 2 
………………………………………………………………………… 
      
Patient # 3 
………………………………………………………………………… 
      
Patient # 4 
………………………………………………………………………… 
      
Patient # 5 
………………………………………………………………………… 
      
 
Where do patients from this facility receive TB treatment (tick all that apply)? 
   
□ on-site 
   
□ off-site 
   
□ BOTH on-site AND off-site 
   
        
If BOTH on-site and off-site, what are the criteria to refer them off-site? 
   
        
        
    
If ON-SITE, is directly observed therapy (DOT) available? 
 
□ Yes □ No 
    
If YES, for what duration? 
   
□ First 2 months of therapy 
   
□ Entire course of therapy 
   
□ Other - specify: ___________________________________________________ 
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What is the frequency of DOT? 
   
□ 7 days/week 
   
□ 5 days/week 
   
□ 3 days/week 
   
□ Other – 
specify;__________________________________________________________    
    
What systems are in place to ensure adherence/follow-up of TB patients? 
   
  
  
  
    
If OFF-SITE, describe the process by which referral information and information 
on treatment progress are transferred between the facility and the referral site.   
  
  
  
    
Does the HIV care and treatment unit have a TB register? 
 
□ Yes □ No 
    
If NO, where are TB patients registered? Tick the appropriate boxes. 
   
□ In the TB unit of the same facility 
   
□ In the clinic the patient is referred to (local clinic) 
   
□ TB patients treated in the HIV care and treatment unit are not registered 
   
□ Elsewhere – specify _________________________________________________ 
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If a TB register is available, record the following numbers for the most recent calendar 
year: 
How many TB patients (all types of TB) were registered? 
  
  
How many Pulmonary TB patients (PTB) were registered? 
  
  
How many PTB patients had a sputum smear/Xpert or culture 
result at diagnosis?   
  
How many PTB patients had a positive sputum smear/Xpert result 
at diagnosis?   
  
How many PTB patients had a positive sputum culture result at 
diagnosis?   
  
How many smear positive PTB patients became smear negative 
after 3 months of treatment?   
  
How many smear positive PTB patients were moved out to another 
facility?   
  
How many bacteriologically confirmed PTB patients were cured1? 
  
  
How many bacteriologically confirmed PTB patients completed 
treatment without proof of cure?  
    
How many bacteriologically confirmed PTB patients died? 
  
  
How many bacteriologically confirmed PTB patients were lost to 
follow up (no follow-up for more than 2 months)?   
  
How bacteriologically confirmed PTB patients were smear positive at the end 
of treatment (treatment failures)? 
    
How many bacteriologically confirmed PTB patients were identified as 
MDR/RR TB patients?  
    
How bacteriologically confirmed PTB patients were identified as XDR-TB 
patients?   
  
 
 
 
1 Definition TB cure: A pulmonary TB patient with bacteriologically confirmed TB at the 
beginning of treatment who was smear- or culture-negative in the last month of 
treatment and on at least one previous occasion. 
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4. Environmental controls: Strategies to remove infectious aerosols after  
 generation 
 
If mechanical ventilation is used, please specify: 
_____________________________________________________________________ 
What air-cleaning methods are used? 
  □ none 
  □ ultraviolet germicidal irradiation (UVGI) 
 □ HEPA filtration 
  
 0 1 2 NA 
4.1. Are there windows on opposite walls leading to 
unrestricted airflow?  
No Only on one 
wall 
Yes NA 
4.2. Are the windows in your facility kept open during 
working hours? 
No Occasionally Yes NA 
4.3. Are there high ceilings (> 3m) in your facility? No Some Yes NA 
4.4. Are fans used to increase circulation of air in your 
area of work? 
No Occasionally Yes NA 
4.5. Do you know the direction of airflow in each 
consultation room in your facility? 
For 
none 
Only for 
some 
Yes NA 
4.6.Do staff in consultation rooms sit with their back 
towards the direction of airflow? 
uncert
ain 
Occasionally Yes NA 
4.7. Is there mechanical ventilation? No  Yes NA 
Max. total score = 14  
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 5. Personal risk reduction strategies to reduce inhalation of infectious aerosols: 
 
Are staff involved in sputum induction procedures? 
 
□ Yes □No 
If NO, skip next question 
   
Do staff use any personal respiratory protection when 
doing sputum induction?    
□ No 
   
□ Yes: surgical mask 
   
□ Yes: N95 or FFP2 mask (personal respirator) 
   
□ Yes: other – please  specify:_______________________________ 
 
    
If N95 or FFP2 masks are available, describe the situations in which N95 or FFP2 
masks are used in the facility (confirm through observation): 
_____________________________________________________________________ 
_____________________________________________________________________ 
        
        
If staff is screened for TB, describe procedures used and frequency of screening. 
____________________________________________________________________
____________________________________________________________________ 
 
Do you know of any staff member who developed active TB in the 
past 2 years? 
□ Yes   □No 
 
If YES, please provide more details (category of staff, workplace, type of TB etc.): 
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
___________________________________________________________________ 
 0 1 2 NA 
5.1. Were staff screened for TB infection symptoms this 
month? 
No Some staff Yes NA 
5.2. Are staff offered confidential voluntary HIV counseling 
and testing? 
No  Yes NA 
5.3. Were staff reminded of the risks of TB for people who 
are living with HIV this month? 
No Some staff Yes NA 
5.4. Is isoniazid preventive treatment available for HIV-
infected staff members? 
No  Yes NA 
5.5 Were staff trained to recognize and diagnose TB this 
month? 
No Some staff Yes NA 
5.6. Are N 95 respirator/masks available this month? No Sometimes Yes NA 
5.7. Were N95 respirator/masks used by staff in high risk 
services this month (e.g. TB, coughing queue)? 
No Sometimes Yes NA 
Max. total score = 14  
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What is the recommended action for HIV-infected workers? 
________________________________________________________________________
________________________________________________________________________ 
        
What are the policies for reassignment if an HIV-infected worker requests it? 
   
________________________________________________________________________
________________________________________________________________________ 
  
   
What HIV-related care and treatment is available on-site for infected staff members? 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
        
        
        
    
 
 
95 
 
6. Facility Layout 
Draw a diagram with measurements of the facility, indicating waiting areas, 
consultation rooms, procedure rooms, dispensary, laboratory and offices. Include 
windows, doors, environmental control measures (fans, UV light, etc) and airflow. 
Indicate where patients are screened for TB and how 1) a TB suspect and 2) a patient 
not suspected of TB flows through the facility during a typical visit. Include photographs 
if possible. 
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Annex 2: KAP survey questionnaire 
 
Demographics 
Age:  
 < 20 years 
 21-30 years 
 31-40 years 
 41-50 years 
 > 50 years 
Gender:   M   F 
Role in the facility (professional category of current position): 
 Doctor 
 Nurse 
 Assistant nurse 
 Midwife 
 Other:_______________ 
  in training 
Level of education:  
 CEP 
 BEPC 
 BAC 
 University degree (e.g. Master, Doctorate) 
 Other: _____________________ 
Duration of work in health care: ________ years 
Current department (if applicable): _________________________ 
Have you ever had TB? 
 Yes  No 
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Have you ever been tested for TB? 
 Yes  No 
Has one of your family members had TB? 
 Yes  No 
Are you vaccinated against TB? (BCG vaccine) 
 Yes  No  Not sure 
Have you ever received training on TB during your work in the hospital? 
 Yes  No  Not sure 
If yes, what kind of training? 
________________________________________________ 
 
Knowledge: 
1. What causes TB? 
 A bacterium  
 I don’t know 
 Other 
2. What are the typical symptoms that are used as an indicator for active 
pulmonary TB?  
 Cough 
 Bloody sputum 
 Fever 
 Weight loss 
 Night sweats 
 I don’t know 
 Other 
3. Can TB be completely cured? 
 Yes  No  Not sure 
4. How is TB transmitted? 
 Through coughed-up droplets via the air 
 I don’t know 
 Other  
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5. What is the standard treatment for TB? 
 Specific antibiotics/ anti-TB regimen/RHZE 
 I don’t know 
 Other 
6. How long does the standard treatment for drug-sensitive (TB 
responding well to therapy) TB of the lungs (pulmonary TB) usually take? 
 6 months 
 I don’t know 
 Other 
7. What can happen if you take your TB drugs incorrectly/disrupt TB 
treatment? (more than one answer possible) 
 Development of resistances 
 Relapse 
 I don’t know 
 Other 
8. Who has a higher risk to get TB than average population? (Name 3 risk 
groups/ risk factors) 
 People living with HIV/AIDS 
 Young children 
 Close contacts of a confirmed case 
 Health care workers  
 Laboratory staff 
 People with medical conditions that weaken the immune system (e.g. 
Cancer, Diabetes) 
 People under immunosuppressive therapy 
 Undernourished people 
 People drinking alcohol 
 People smoking 
 People using drugs 
 Prisoners 
 I don’t know 
 Other 
9. Can you get TB when you are vaccinated with BCG? 
 Yes  No  Not sure  
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10. Is there a relationship between HIV and TB? 
 Yes (go to 10.1)  No  Not sure 
10.1. What is it? 
  Person with HIV is more 
likely to develop TB 
 I don’t know 
 Other 
 
 
11. What is the most frequently used diagnostic laboratory test to 
diagnose TB in Gabon? 
 Sputum smear microscopy 
 I don’t know 
 Other 
12. What is the difference between latent TB infection and TB disease? 
(More than one answer possible) 
 TB infection is asymptomatic 
 TB infection is not contagious 
 I don’t know 
 Other 
13. When you are in the same room with a TB-infected patient, how can 
you minimize the risk of getting TB from that patient? (more than one 
answer possible) 
 Increase airflow (e.g. open windows and doors, fan) 
 Let patient perform cough hygiene (mask, tissue, arm, etc.) 
 Wear respirator  
 I don’t know 
 Other 
 14. What is MDR-TB? 
 TB that is resistant to the most important anti-TB drugs/ TB that doesn’t 
respond to the usual treatment 
 I don’t know 
 Other 
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15. How can you get MDR-TB? (more than one answer possible) 
 Through infection from another person with MDR-TB 
 Through incorrect treatment 
 I don’t know 
 Other 
16. Is MDR-TB curable? 
 Yes  No  Not sure 
 
Attitude 
1. Do you think you could get TB? 
 Yes  No  Not sure 
If not, why?_____________________________________________________ 
_______________________________________________________________ 
2. Are you scared of getting TB? 
 Yes  No  Not sure 
If yes, why?_____________________________________________________ 
_______________________________________________________________ 
3. Would you continue to socialize with your friend, if he was diagnosed 
with TB? 
 Yes  No  Not sure 
4. Would you share the same cutlery, plates and glasses with a family 
member, if he was infected with TB? 
 Yes  No  Not sure 
5. Would you say that TB is a stigmatized disease? 
 Yes  No  Not sure 
6. Would you like to learn more about TB? 
 Yes  No  Not sure 
7. Would you be willing to get tested for TB regularly? 
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 Yes  No  Not sure 
If not, why?_____________________________________________________ 
_______________________________________________________________ 
 
8. Do you feel TB is a major threat to public health in Gabon? 
 
 Yes  No  Not sure 
 
9. Do you think there is a need of improvement in TB control in your 
region? 
 Yes  No  Not sure 
If yes, how?_____________________________________________________ 
_______________________________________________________________ 
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Practice 
1. When a patient says he has been coughing for a month, I suspect TB 
 Never Sometimes  Most of the times  Always 
2. I separate coughing patients from other patients 
 Never Sometimes  Most of the times  Always 
3. When I deal with a coughing patient I wear a mask 
 Never Sometimes  Most of the times  Always 
4. When I deal with a confirmed active TB patient, I wear a mask 
 Never Sometimes  Most of the times  Always 
5. I give patients who arrive with a cough a mask 
 Never Sometimes  Most of the times  Always 
6. When a TB patient is in the room, I open windows and doors to increase 
natural ventilation 
 Never Sometimes  Most of the times  Always 
7. When dealing with a TB patient, I turn on the fan to increase ventilation 
 Never Sometimes  Most of the times  Always 
8. When a patient arrives at my facility with a cough, I prioritize him/her in 
comparison to patients without cough 
 Never Sometimes  Most of the times  Always 
9. If a patient is newly diagnosed with TB, I give him/her information about 
his/her disease 
 Never Sometimes  Most of the times  Always 
10. I explain coughing patients how they can practice cough hygiene, in 
order to avoid infecting other people around them 
 Never Sometimes  Most of the times  Always 
 
